Introduction {#s1}
============

We are interested in understanding how metabolism impacts meiotic progression during oogenesis. [T]{.ul}arget [o]{.ul}f [R]{.ul}apamycin [C]{.ul}omplex 1 (TORC1) is a multi-protein complex that functions as a master regulator of metabolism ([@bib61]; [@bib53]; [@bib40]). In the presence of adequate nutrients and positive upstream growth signals, TORC1, which contains the serine/threonine kinase Target of Rapamycin, becomes active and functions to stimulate growth and inhibit catabolic metabolism through the phosphorylation of down-stream effector proteins. The [Se]{.ul}h1 [A]{.ul}ssociated [C]{.ul}omplex [I]{.ul}nhibits [T]{.ul}ORC1 (SEACIT), originally identified in yeast, inhibits TORC1 activity in response to amino acid limitation ([@bib78]; [@bib18]; [@bib101]; [@bib3]; [@bib81]). SEACIT, known as the [G]{.ul}AP [A]{.ul}ctivity [To]{.ul}wards [R]{.ul}ags complex 1 (GATOR1) in metazoans, is comprised of three highly conserved proteins Npr2/Nprl2, Npr3/Nprl3 and Iml1/Depdc5 ([@bib3]; [@bib81]). In *Drosophila* and mammals, depleting any of the three GATOR1 components results in increased TORC1 activity and growth, as well as a reduced response to amino acid starvation ([@bib49]; [@bib3]; [@bib98]; [@bib19]; [@bib8]; [@bib69]). Thus, the role of the SEACIT/GATOR1 complex in the regulation of TORC1 activity is highly conserved in eukaryotes.

The multi-protein GATOR2 complex, known as [Se]{.ul}h1 [A]{.ul}ssociated [C]{.ul}omplex [A]{.ul}ctivates [T]{.ul}ORC1 (SEACAT) in yeast, inhibits the activity of GATOR1 and thus functions to activate TORC1 ([@bib3]; [@bib98]) ([Figure 1A](#fig1){ref-type="fig"}). In metazoans, the GATOR2 complex functions in multiple amino acid sensing pathways ([@bib3]; [@bib81]; [@bib10]; [@bib82]; [@bib46]; [@bib8]). In tissue culture cells, depleting GATOR2 components results in the constitutive activation of GATOR1 and the permanent downregulation of TORC1 activity ([@bib3]; [@bib100]). However, genetic studies of the role of individual GATOR2 components in *Drosophila*, indicate that the requirement for the GATOR2 complex is more nuanced when examined in the context of a multicellular animal ([@bib37]; [@bib99]). For example, mutations in the GATOR2 component *mio,* result in a block to oocyte growth and differentiation, due to the constitutive downregulation of TORC1 activity in the female germline ([@bib37]; [@bib99]). However, *mio* is not required to maintain TORC1 activity in most somatic tissues of *Drosophila* ([@bib99]). Why there is a tissue specific requirement for *mio* in the female germline of *Drosophila* is currently unknown.

![Mio prevents the constitutive downregulation of TORC1 activity in response to meiotic DSBs.\
(**A**) The GATOR2 complex opposes the activity of the TORC1 inhibitor GATOR1. (**B**) Representative ovaries from wild type (WT), *mio^2^*, double-mutant *mio^2^, mei-W68^1^* and *mei-W68^1^* females. Scale bar, 1000 μm. (**C**) Western blot of p-S6K and total-S6K levels of whole ovaries prepared from WT, *mio^2^* and *mio^2^, mei-w68^1^* and *mei-W68^1^* mutant females. (**D**) Quantification of p-S6K levels relative to total S6K. Unpaired student T-test was used to calculate the statistical significance. Error bars represent the standard deviation (SD) for three independent experiments. \*p\<0.05.](elife-42149-fig1){#fig1}

In single celled eukaryotes, nutrient limitation often facilitates meiotic entry ([@bib96]). In the yeast *Saccharomyces cerevisiae*, the down-regulation of TORC1 by SEACIT/GATOR1 in response to amino acid stress promotes both meiotic entry and early meiotic progression ([@bib17]; [@bib42]; [@bib78]; [@bib88]). Surprisingly, as is observed in yeast, during *Drosophila* oogenesis the GATOR1 complex promotes meiotic entry ([@bib98]). These data raise the intriguing possibility that in *Drosophila* the GATOR1 complex and low TORC1 activity may be critical to the regulation of additional events of the early meiotic cycle.

Here we report that the GATOR complex is critical to the response to meiotic DSB during *Drosophila* oogenesis. We find that restraining TORC1 activity via a pathway that involves both GATOR1 and the Tuberous sclerosis complex (TSC) promotes the timely repair of meiotic DSBs and prevents the hyperactivation of p53 in the female germline. Notably, the delayed repair of meiotic DSBs in GATOR1 mutants is due, at least in part, to the hyperactivation of the TORC1 target S6K. Conversely, our data indicate that the GATOR2 component Mio opposes the activity of GATOR1 in the female germline, thus preventing the constitutive downregulation of TORC1 activity and allowing for the growth and development of the oocyte in later stages of oogenesis. Thus, we have identified a regulatory loop required to modulate TORC1 activity in response to meiotic DSBs during *Drosophila* oogenesis. Finally, during the course of our studies, we observed that the GATOR1 complex prevents the derepression of retrotransposon expression in the presence of meiotic DSBs.

Results {#s2}
=======

Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs {#s2-1}
--------------------------------------------------------------------------------------

The GATOR2 complex inhibits the TORC1 inhibitor GATOR1 ([Figure 1A](#fig1){ref-type="fig"}). Ovaries from mutants of the GATOR2 component *mio,* have reduced TORC1 activity and are severely growth restricted ([Figure 1B--D](#fig1){ref-type="fig"}) ([@bib37]; [@bib98]). In our previous studies, we demonstrated that the *mio* ovarian phenotypes result from the constitutive downregulation of TORC1 activity via a GATOR1 dependent pathway ([@bib98]). Thus, removing GATOR1 activity in the *mio* mutant background, as is observed in *mio, nprl3* double mutants, results in increased TORC1 activity and rescues the *mio* ovarian phenotypes ([@bib98]).

Surprisingly, *mio* mutants are also suppressed by blocking the formation of meiotic DSBs, with approximately 70% of *mio* ovaries achieving wild-type levels of growth when double mutant for genes required to generate meiotic DSBs ([Figure 1B](#fig1){ref-type="fig"}) ([@bib37]). One model to explain this observation is that meiotic DSBs promote the downregulation of TORC1 activity in the early meiotic cycle and that *mio* is required to oppose or attenuate this response. To test this idea, we examined if blocking the formation of meiotic DSBs in the *mio* mutant background resulted in increased TORC1 activity. Towards this end, we compared the phosphorylation status of S6 kinase, a downstream TORC1 target, in ovaries from *mio^2^* single mutant versus *mio, mei-W68* double mutant ovaries ([Figure 1C,D](#fig1){ref-type="fig"}). For these experiments, we used null alleles of both *mio (mio^2^)* and *mei-W68* (*mei-W68^1^*) ([@bib73]; [@bib37]). *mei-W68* (*SPO11* homolog) is a highly-conserved enzyme required for the generation of meiotic DSBs ([@bib73]; [@bib86]; [@bib59]). We found that relative to ovaries from *mio* single mutants, *mio, mei-W68* double mutants have increased levels of TORC1 activity as measured by the phosphorylation of S6K ([Figure 1C,D](#fig1){ref-type="fig"}). Notably, *mio^2^*, *mei-W68^1^* mutants have TORC1 activity levels similar to that observed in *mei-W68^1^* single mutants ([Figure 1C,D](#fig1){ref-type="fig"}). Why ovaries from *mei-W68^1^* single mutants have decreased levels of TORC1 activity relative to wild type ovaries is unclear. In addition to increasing TORC1 activity, blocking the formation of meiotic DSBs partially rescues *mio* mutant fertility, with *mio^2^, mei-W68^1^* double mutants laying approximately ten times more eggs than *mio^2^* single mutants ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Finally, mutants in the *spnA* homolog Rad51, which fail to repair meiotic DSBs, also have decreased TORC1 activity relative to wild-type ovaries ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). From these data, we conclude that the constitutive downregulation of TORC1 activity in *mio* mutants is potentiated, at least in part, by the presence of meiotic DSBs.

To refine when meiotic DSBs impact TORC1 activity during meiosis, we stained ovaries with antibodies against the phosphorylated form of the TORC1 target 4E-BP ([@bib92]). TORC1-mediated phosphorylation of 4E-BP, known as Thor in Drosophila, initiates cap-dependent translation by eIF4E ([@bib25]) ([@bib92]). In *Drosophila*, oogenesis begins in region 1 of the germarium when a germline stem cell divides to produce a cystoblast that undergoes four mitotic divisions, with incomplete cytokinesis, to produce a 16 cell interconnected germline cyst ([Figure 2A](#fig2){ref-type="fig"}) ([@bib13]). In late region 2a of the germarium, Spo11/Mei-W68 generates the meiotic DSBs that initiate meiotic recombination ([@bib73]; [@bib36]). As meiosis proceeds, meiotic DSBs are repaired such that by late region 2b, only a small fraction of oocytes retain unrepaired DSBs ([@bib74]; [@bib77]). We found that the levels of p4E-BP are low in the vast-majority of ovarian cysts undergoing mitotic divisions in region 1 ([Figure 2A',B](#fig2){ref-type="fig"}). However, a small number (0.5 per germarium, n = 57) of region one ovarian cysts have dramatically higher levels of p4E-BP staining ([Figure 2A"](#fig2){ref-type="fig"}, arrowhead). These observations are consistent with the previously reported oscillation of TORC1 activity during the mitotic cell cycle in larval imaginal discs ([@bib47]; [@bib84]). As ovarian cysts enter meiosis I in early region 2a of the germarium, the levels of p4E-BP are low ([Figure 2A',B](#fig2){ref-type="fig"}). As ovarian cysts are encapsulated by follicle cells in germarial region 2b, the levels of p4E-BP begin to rise and remain above those observed in region one and early region 2a ([Figure 2B](#fig2){ref-type="fig"}, arrow). In contrast to what is observed in wild type, in *mio* mutant ovarian cysts, p4E-BP levels remain low in germline cells in region 2b and beyond ([Figure 2C](#fig2){ref-type="fig"}, arrow). Consistent with the western blot analysis, *mio, mei-w68* double mutant ovarian cysts have an approximately three-fold increase in p4E-BP staining in region 2b of the germarium relative to *mio* mutants ([Figure 2C,E and H](#fig2){ref-type="fig"}) Notably, the increase in TORC1 activity in the *mio, mei-w68* double mutants is restricted to the germline, consistent with blocking meiotic DSBs having cell autonomous effects on TORC1 activity in the germline. Additionally, consistent with our western blot analysis in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, ovarian cysts from *spnA/Rad51* mutants, which do not repair meiotic DSBs, have reduced levels of p4E-BP staining ([Figure 2F](#fig2){ref-type="fig"}). Taken together these data strongly suggest that *mio* is required to oppose the downregulation of TORC1 activity triggered by the presence of meiotic DSBs.

![Suppressing the production of meiotic DSBs increases p4E-BP staining in the female germline of *mio* mutants.\
(**A**) Schematic representation of the *Drosophila* germarium. (**A'A'**) pseudo-color representation of p-4E-BP staining, arrowhead denotes a region one ovarian cyst with high p-4E-BP levels. Ovaries from (**B**) wild type (**C**) *mio^2^*, (**D**) *mei-W68^1^*, (**E**) *mio^2^; mei-W68^1^*, (**F**) *spnA^1^*, (**G**) *thor^2^* females stained for C(3)G (cyan) to mark the synaptonemal complex, p-4E-BP (white), Vasa (magenta) to highlight the germline cytoplasm and DNA (Blue). (**B**) In wild-type ovarian cysts, p-4E-BP staining begins to increase in region 2b (arrow). (**C**) In *mio* mutant ovarian cysts, p-4E-BP levels remain low in region 2b and region 3. (**D,E**) *mio*, *mei-W68* double mutants have p-4E-BP expression levels similar to *mei-W68* single mutants. (**F**) *spnA* mutants, which fail to repair meiotic DNA breaks, have low levels of p-4E-BP staining (**G**) *thor^2^*/4E-BP null mutants serve as a negative control. (**H**) p-4E-BP intensity measurement of region 2b data (**B**)-(**G**). Scale bar: 7 μm. Unpaired T-student test was used to calculate statistical significance. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001.](elife-42149-fig2){#fig2}

To examine if meiotic DSBs activate the downregulation of TORC1 activity via GATOR1, or activate a parallel TORC1 inhibitory pathway, we performed epistasis analysis with a null mutant of the GATOR1 component *nprl3* (*nprl3^1^*) and a mutant of *mei-P22,* a gene required for the generation of meiotic DSBs ([@bib72]; [@bib59]; [@bib37]). The *mei-P22^P22^* mutation, which rescues the *mio* ovarian growth deficit, blocks the formation of meiotic DSBs resulting in meiotic exchange rates of zero or near zero ([@bib72]; [@bib59]; [@bib37]). We found that *mei-P22^P22^* single mutants had pS6K levels that were not significantly different than ovaries from wild-type females when measured by western blot ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). This result is not surprising when one considers the anatomy of the *Drosophila* ovary. In wild-type ovaries, meiotic DSBs are present in only a small number of 16 cell cysts in the germarium. Moreover, meiotic DSBs are repaired prior to the rapid growth of the egg chamber. Thus, in wild type females, ovarian cysts that contain meiotic DSBs represent an exceedingly small percentage of the tissue in the ovary. Therefore, it is unlikely that increasing TORC1 activity in only a small number of germarial ovarian cysts would result in an increase in TORC1 activity in the ovary that could be observed by western blot. In contrast, note that ovaries from *spnA* mutants, which retain DSBs throughout oogenesis, have low TORC1 activity relative to wild type ovaries ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Consistent with *mei-P22* mutant ovaries not having increased TORC1 activity, we found that *mei-P22, nprl3* double-mutant ovaries do not have pS6K levels above those of *nprl3* single mutants. Thus, using epistasis analysis we were unable to definitely determine if meiotic DSBS trigger the downregulation of TORC1 activity via the GATOR1/TSC pathway.

We were interested in defining the upstream pathway that connects meiotic DSBs to the TORC1 regulatory machinery. *Ataxia telangiectasia* (ATM), known as *telomere fusion* (*tefu*) in *Drosophila*, regulates both the generation and the repair of meiotic DSBs ([@bib43]). *atm/tefu* mutants produce supernumerary meiotic DSBs. Therefore, we examined a downstream target and effector of *atm/tefu*, *chk2*, which has not been implicated in the generation of meiotic DSBs. *chk2*, known as *loki* in *Drosophila*, is a critical component of the DNA damage response pathway and has multiple targets involved in DNA repair, cell cycle progression and apoptosis ([@bib105]). We determined that removing *chk2/loki* activity in the *mio* mutant background, by generating double-mutants of *loki* and *mio* null alleles, partially rescued the *mio* mutant phenotype ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Specifically, we found that *mio^2^, loki^6^* double mutants are approximately twice the size of *mio^2^* single mutants. In contrast, we previously demonstrated that the downregulation of TORC1 activity observed in the *mio* mutant is not triggered by the upstream activity of Ataxia Telangiectasia--Related (ATR), known as *mei-41* in *Drosophila* ([@bib37]; [@bib43]). These data suggest that DSBs communicate to the TORC1 machinery at least in part through the checkpoint protein Chk2/Loki.

GATOR1 promotes the repair of meiotic DSB {#s2-2}
-----------------------------------------

In previous work we found that the GATOR1 complex downregulates TORC1 activity to facilitate meiotic entry in *Drosophila* ovarian cysts ([@bib17]; [@bib42]; [@bib78]; [@bib88]; [@bib98]). However, the delay in meiotic entry observed in *Drosophila* GATOR1 mutants is not fully penetrant and therefore unlikely to be the sole cause of the infertility observed in GATOR1 mutant females ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}) ([@bib98]). Considering our findings that meiotic DSBs serve to promote and/or reinforce low TORC1 activity after the mitotic/meiotic switch, we hypothesized that as is observed in yeast, the downregulation of TORC1 activity may be critical to the regulation of additional early meiotic events, including the repair of meiotic DSBs in *Drosophila*.

To test this hypothesis, we examined the behavior of meiotic DSBs in null alleles of *nprl2*, *nprl3* and *iml1* ([@bib8]; [@bib99]). During *Drosophila* oogenesis, the kinetics of DSB formation and repair can be followed using an antibody against the phosphorylated form of His2Av known as γ-His2Av ([@bib66]; [@bib74]). *Drosophila* ovarian cysts generate meiotic DSBs after the initiation of synaptonemal complex (SC) formation in region 2a of the germarium ([@bib9]; [@bib39]; [@bib74]). γ-H2Av nuclear foci are first observed in the two pro-oocytes, which are in early pachytene ([@bib39]; [@bib74]). A small number of DSBs are also observed in the pro-nurse cells ([@bib74]; [@bib77]). As meiosis proceeds and the DSBs are repaired, γ-H2Av-positive foci decrease in number and mostly disappear by late region 2b ([@bib39]; [@bib74]). γ-H2Av signals are rarely detected in region three oocytes ([Figure 3A](#fig3){ref-type="fig"}, arrow). Analysis of mutants that fail to repair DSBs, and thus capture the total number of meiotic breaks, indicate that wild-type oocytes generate approximately 20--25 Spo11/Mei-W68 dependent breaks during oogenesis ([@bib74]; [@bib43]).

![GATOR1 influences the steady state number and persistence of DSBs in early oocytes.\
Ovaries from (**A**) wild type, (**B**) *nprl2^1^*, (**C**) *nprl3^1^/Df, (**D**) iml^1^/Df, (**E**) nanos-GAL4; UAS-Nprl3; nprl3^1^/Df, (**F**) mei-P22^P22^, nprl3^1^*, and (**G**) *spnA^1^*/*spnA^093^* females were stained for C(3)G (green, **A'--G'**) and γ-H2Av (red, **A--G**). C(3)G marks the synaptonemal complex (SC) and is used to mark oocytes and follow meiotic progression. γ-H2Av marks DSBs. Scale bars, 10 μm. In wild type oocytes, meiotic DSBs are induced in region 2a and repaired by region 3 (arrow). In GATOR1 mutants, DSBs persist in region three oocytes. In *nanos-GAL4; UAS-Nprl3; nprl3^1^/Df oocytes,* DSBs are repaired by region 3. *mei-P22^P22^, nprl3^1^ mutant*s have no DSBs. (**H**) Ovaries from wild type, *nprl2^1^*, *nprl3^1^/Df, iml^1^/Df, spn-A^1^/spn-A^093A^*, *nprl2^1^; spnA^1^/spnA^093^*,*mei-P22^p22^,nprl3^1^* and *nanos-GAL4; UAS-Nprl3; nprl3^1^/Df* flies were stained for C(3)G (green) and γ-H2Av (red). Representative immunofluorescent microphotographs of the γ-H2Av foci in region 2a oocyte are shown. (**I**) Percentage of region three oocytes with γ-H2Av foci. (**J and K**) Quantification of γ-H2Av foci in region 2a oocytes. Unpaired T-student test was used to calculate the statistical significance. Error bars represent SD from at least three independent experiments.\*\*p\<0.01, \*\*\*\*p\<0.0001, ns: no significance. Note that the three GATOR1 mutants, *nprl3^1^*, *nprl2^1^* and *iml1^1^* are null alleles ([@bib8]; [@bib99]).](elife-42149-fig3){#fig3}

To determine if GATOR1 regulates the behavior of meiotic DSBs in *Drosophila*, we compared the pattern of γ-H2Av foci in wild-type versus GATOR1 mutant ovaries using antibodies against γ-H2Av and the SC component C(3)G, to highlight DSBs and oocytes respectively ([@bib37]; [@bib74]). We determined that while the majority of wild-type oocytes had repaired all of their DSBs and thus had no γ-H2Av foci by region 3 of the germarium, in GATOR1 mutants between 50--80% of region three oocytes are γ-H2Av positive ([Figure 3A--E,H](#fig3){ref-type="fig"}, arrow) ([@bib74]). Moreover, GATOR1 mutant oocytes had a significant increase in the steady state number of γ-H2Av foci per oocyte nucleus in region 2a of the germarium relative to wild-type oocytes ([Figure 3J](#fig3){ref-type="fig"}). From these data, we conclude that the GATOR1 complex influences the behavior of meiotic DSB during early oogenesis.

Next, we examined if the altered γ-H2Av pattern observed in GATOR1 mutants was dependent on the meiotic DSB machinery. Alternatively, the extra DSB may be induced during the premeiotic S phase, as is observed in mutants of the CycE/Cdk2 inhibitor *dacapo* ([@bib33]). To address this question, we analyzed *nprl3*, *mei-P22* double-mutants. As discussed above, *mei-P22* is required for the formation of meiotic DSBs in *Drosophila* ([@bib59]). We determined that double-mutant *nprl3*, *mei-P22* oocytes had no γ-H2Av foci ([Figure 3F,I and J](#fig3){ref-type="fig"}). These data indicate that the increase in the steady state number of γ-H2Av foci, as well as the retention of these foci into region 3 of the germarium, are dependent on the meiotic DSB machinery.

During the development of wild-type *Drosophila* oocytes, the generation and repair of meiotic DSBs is asynchronous. Thus, the number of γ-H2Av foci observed in an oocyte at any single time point, is less than the total number of DSBs generated during the lifetime of the oocyte.

([@bib74]; [@bib43]). We noticed that the number of γ-H2Av foci observed in GATOR1 mutant oocytes is never more than the 20--25 foci observed in mutants in the DSB repair pathway ([Figure 3J](#fig3){ref-type="fig"}) ([@bib74]). This observation suggested that the increase in the steady state number of DSBs observed in GATOR1 mutants may result from the delayed repair of meiotic DSBs, rather than the production of supernumerary Mei-W68/Spo11 induced DSBs. To test this hypothesis, we generated *nprl2*, *spnA* double mutants. Importantly, *spnA* mutants, including the *spnA^1^/spnA^093^* transheterozygotes used here, fail to repair meiotic DSBs ([Figure 3G](#fig3){ref-type="fig"}) ([@bib89]; [@bib44]). If *nprl2* mutants make extra meiotic breaks, then the number of foci in the *nprl2, spnA* double mutants should be higher than either single mutant. However, we found that the *nprl2, spnA* double-mutants contained approximately the same number of γ-H2Av foci as *spnA* single mutants ([Figure 3K](#fig3){ref-type="fig"}). Thus, mutations in *nprl2* do not result in the production of extra meiotic breaks. Taken together, our data strongly suggest that the GATOR1 complex influences the repair, rather than the production, of meiotic DSBs.

In *Drosophila*, the failure to repair meiotic DSBs activates an ATR-dependent checkpoint that disrupts dorsal ventral (DV) patterning in the egg ([@bib23]; [@bib24]). We find that approximately 98% of eggs from *nprl3^1^* mothers exhibit no DV patterning defects (n = 308). Moreover, the approximately 2% of eggs from *nprl3* mothers that have a possible DV patterning defect, are smaller and have a collapsed egg shell. Thus, the DV patterning defects observed in eggs from *nprl3* mutant mothers may reflect a general problem in egg chamber growth and development. In contrast, 77% of eggs from mutant *spnA^1^* mothers exhibit DV patterning defects (n = 271) ([@bib89]). Why we do not observe DV patterning defects in GATOR1 mutants is unclear but may indicate that high TORC1 activity delays but does not block all aspects of meiotic DNA repair. Alternatively, high TORC1 activity may override the translational repression of the patterning gene *gurken* that drives the pattern defects observed in DNA repair mutants such as *spnA* ([@bib1]).

Co-depleting S6K rescues the increase in the steady state number of meiotic DSBs in iml1 germline depletions {#s2-3}
------------------------------------------------------------------------------------------------------------

TORC1 stimulates protein synthesis and cell growth through the phosphorylation of downstream effector proteins that promote anabolism and inhibit catabolism ([@bib31]; [@bib102]). We wanted to identify the pathways downstream of TORC1 that impact the repair of meiotic DSBs ([@bib99]). Towards this end we examined the role of three well known downstream targets of TORC1 phosphorylation, S6K, Atg1 and 4E-BP in the regulation of meiotic DSBs ([@bib54]). We determined that the depletion of *iml1* by RNAi, recapitulates the *iml1* mutant phenotype resulting in an increase in the steady state number of meiotic DSBs in the germarium ([Figure 4](#fig4){ref-type="fig"}). TORC1 phosphorylation activates S6K, a serine--threonine kinase that promotes translation and growth ([@bib91]). In mammals, S6K links growth control to the DNA damage response ([@bib104]). To determine if the hyperactivation of S6K contributes to the defects in the repair of meiotic DSBs observed in GATOR1 mutants, we reduced the dose of the S6K gene by half in the *iml1* germline depletions. Notably, reducing the dose of S6K lowered the steady state number of meiotic DSBs in *iml1* RNAi depletions to levels observed in controls ([Figure 4A,B](#fig4){ref-type="fig"}). These data indicate that the delay in the repair of meiotic DSBs observed in GATOR1 mutant ovaries is at least in part the result of the hyperactivation of S6K.

![Reducing the dose of S6K rescues the meiotic DSB phenotype in *iml1* knockdowns.\
(**A**) γ-H2Av foci in region 2a oocytes in the indicated genotypes. (**B**) Quantification of γ-H2Av foci in region 2a oocytes in the indicated genotypes. Note that meiotic DSBs were increased in *nanos-GAL4; iml1*^RNAi^ females. Moreover, removing a single copy of S6K in the *nanos-GAL4; iml1*^RNAi^ background reduced the steady state number of meiotic DSBs in *nanos-GAL4; iml1*^RNAi^; *S6K^l-1^*/+ females. Unpaired T-student test was used to calculate statistical significance. \*p\<0.05, \*\*\*\*p\<0.0001, n.s.: no significance. (**B**).](elife-42149-fig4){#fig4}

High TORC1 inhibits the activation of autophagy via the inhibitory phosphorylation of Atg1 and Atg13 ([@bib22]). In our previous work, we determined that GATOR1 mutants fail to undergo autophagy in response to starvation due to inappropriately high TORC1 activity ([@bib99]). Recent evidence suggests that blocking autophagy inhibits DSB repair through homologous recombination ([@bib32]). Therefore, to examine if a block to autophagy is responsible for the delay in the repair of meiotic DSBs we generated germline clones of a null allele of *atg1*, which is required for the activation of autophagy in *Drosophila* ([@bib85]). We found that late region 2a oocytes in *atg1^Δ3D^* germline clones had approximately the same number of γ-H2Av foci as similarly staged wild-type oocytes ([Figure 4B](#fig4){ref-type="fig"}). From these data, we conclude that the increased number of meiotic DSBs observed in GATOR1 mutants is unlikely to be the result of a block to autophagy. Similarly, we found that null mutants of the translational inhibitor 4E-BP/*thor*, which is inhibited by TORC1 activity do not have an increased steady state number of meiotic DSBs. These data argue that the increase in the steady state number of meiotic DSBs in GATOR1 mutants is not the result of increased translation due to a block to 4E-BP translational inhibition.

GATOR1 mutants hyperactivate p53 in response to meiotic DSBs p53, a transcription factor that mediates a conserved response to genotoxic stress, regulates early meiotic events in multiple organisms ([@bib90]; [@bib55]; [@bib58]; [@bib70]). During *Drosophila* oogenesis, the generation of meiotic DSBs results in the brief activation of p53 and the expression of downstream targets ([Figure 5A](#fig5){ref-type="fig"}) ([@bib63]). To determine if GATOR1 mutants experience increased genotoxic stress during oogenesis, we used a reporter construct to assay p53 activity. The p53-GFPnls reporter construct contains the Green Fluorescent Protein (GFP) under the control of an enhancer from the p53 transcriptional target *reaper* ([@bib63]). In wild-type ovaries, a faint signal from the p53-GFPnls reporter is first observed in region 2a of the germarium, concurrent with the generation of meiotic DSBs ([Figure 5A](#fig5){ref-type="fig"}, arrow) ([@bib63]). As ovarian cysts continue to develop, the p53-GFPnls signal rapidly dissipates as meiotic DSBs are repaired ([Figure 5A](#fig5){ref-type="fig"}, arrowhead) ([@bib63]). By region 3 of the germarium less than 5% of p53-GFPnls ovarian cysts contain detectable levels of GFP ([Figure 5A](#fig5){ref-type="fig"}). In contrast, the germaria of all three GATOR1 mutants exhibited a dramatic increase in both the strength and the duration of p53-GFPnls expression in the germarium, with strong GFP signal observed in nearly 80% of region three ovarian cysts ([Figure 5A--D,F,G](#fig5){ref-type="fig"}, arrowheads). Homozygous germline clones of the *iml1^1^* and *nprl3^1^* null alleles, hyperactivate p53 confirming that GATOR1 activity is required cell autonomously in the female germline ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

![GATOR1 prevents p53 hyperactivation in Drosophila early ovarian cysts Ovaries from (**A**) *p53R-GFP*, (**B**) *nprl2^1^*; *p53R-GFP, (**C**) p53R-GFP;nprl3^1^/Df, (**D**) p53R-GFP; iml^1^/Df* and *(**E**) p53R-GFP; mei-P22^p22^, nprl3^1^* were stained for GFP (green) and 1B1 (red).\
Germarial regions are defined by 1B1 staining. In wild-type ovaries the p53-GFP reporter is briefly activated in region 2 (indicated by arrow). Note the low level of GFP staining. In contrast, in GATOR1 mutants, p53R-GFP is robustly activated with strong GFP signal often persisting into germarial region three and beyond. Additionally, in GATOR1 mutant germaria, p53R-GFP is frequently activated in germline stem cell (GSC) and daughter cystoblasts (CB). In *mei-P22^p22^, nprl3^1^ double mutant germaria, the hyperactivation of* p53R-GFP is rescued in region 2a ovarian cysts. However, p53-GFP activation in GSC and CB is retained in the double mutants (asterisk) indicating that in these cells the activation of p53 is not contingent on the presence of meiotic DSBs. Scale bars, 10 μm. (**F**) Percentage of germaria with sustained p53R-GFP signal in region 3. (**G**) Percentage of germaria with high p53R-GFP signal in region 2. (**H**) Percentage of germaria with p53R-GFP expression in GSC and CB. Unpaired student T-test was used to calculate the statistical significance Error bars represent SD from at least three independent experiments. \*\*p\<0.01, \*\*\*\*p\<0.0001.](elife-42149-fig5){#fig5}

We predicted that the persistent hyperactivation of p53 in the female germ line of GATOR1 mutants is due to the delayed repair of meiotic DSBs. To test this model, we examined p53 activation in the *mei-P22*, *nprl3* double mutant. Strikingly, inhibiting meiotic DSBs strongly suppressed the expression of p53-GFPnls in the *nprl3* mutant background ([Figure 5E](#fig5){ref-type="fig"}). From these observations, we infer that in GATOR1 mutant ovaries, the hyperactivation of p53 is downstream of Spo11/Mei-W68-induced DBS. Moreover, we conclude that the GATOR1 complex is required to oppose genotoxic stress triggered by meiotic DSBs and/or other downstream events of meiotic recombination.

Recent evidence indicates that p53 is activated in germline stem cells of *Drosophila* after exposure to cellular stresses, including deregulated growth and ionizing radiation ([@bib103]; [@bib64]). The GATOR1 complex inhibits TORC1 activity and is required to restrain growth in *Drosophila* ([@bib98]; [@bib8]). As was reported with other mutants that deregulate growth ([@bib103]), we found that the p53-GFPnls reporter construct is robustly activated in the germline stem cells and their near descendants in GATOR1 mutant females ([Figure 5B--D,H](#fig5){ref-type="fig"}). Consistent with the restriction of Mei-W68/Spo11 activity to meiotic cysts, the *mei-P22, nprl3* double mutants retain p53-GFPnls expression in stem cells even though the meiotic activation of the p53- GFPnls reporter is lost in regions 2a and 2b of the germarium in the *mei-P22, nprl3* double mutant ([Figure 5E--G](#fig5){ref-type="fig"}). Thus, an independent cellular stress, likely related to deregulated metabolism or growth, activates p53 in the germline stem cells and cystoblasts of GATOR1 mutant females.

Tsc1 germline depletions phenocopy GATOR1 mutants {#s2-4}
-------------------------------------------------

The most parsimonious interpretation of our data is that in GATOR1 mutant ovaries, high TORC1 activity opposes the timely repair of meiotic DSBs and increases genotoxic stress. To test this model, we depleted the [T]{.ul}uberous [s]{.ul}clerosis [c]{.ul}omplex (TSC) component Tsc1 from the female germline. TSC is a potent inhibitor of TORC1 that directly inhibits the small GTPase Rheb, a critical activator of TORC1 ([@bib38]; [@bib106]). We determined that depleting *Tsc1* in the female germline using RNAi, resulted in the robust expression of p53-GFPnls during the early meiotic cycle ([Figure 6A--D](#fig6){ref-type="fig"}). Moreover, as was observed in GATOR1 mutants, *Tsc1^RNAi^* oocytes had an increase in the steady state number of γ-H2Av foci as well as an increase in the percentage of oocytes that retained γ-H2Av positive into region 3 of the germarium ([Figure 6E,F](#fig6){ref-type="fig"}). Taken together our data support the model that the tight control of TORC1 activity by both GATOR1 and TSC is essential to the proper regulation of meiotic DSBs during *Drosophila* oogenesis.

![The TORC1 inhibitor TSC1 promotes genomic stability in early oocytes.\
Ovaries from (**A**) *p53R-GFP; MTD \>mCherry RNAi* and (**B**) *p53R-GFP; MTD \>Tsc1 RNAi* flies were stained for GFP (green) and 1B1 (red). In the *mCherry RNAi* (control) ovaries the p53-GFP expression is very low. In contrast, the *Tsc1 RNAi* ovaries have sustained GFP signal that persists into germarial region 3. Scale bars, 10 μm. (**C**) Percentage of germaria with strong p53R-GFP signal in region 2. (**D**) Percentage of germaria with sustained p53R-GFP signal in region 3. The γ-H2Av foci were determined in *MTD \>mCherry RNAi* and *MTD \>Tsc1 RNAi* ovaries. (**E**) Percentage of region three oocytes with γ-H2Av foci. (**F**) Quantification of γ-H2Av foci per oocyte in region 2a. Unpaired student T-test was used to calculate the statistical significance Error bars represent SD from at least three independent experiments. \*p\<0.05, \*\*\*\*p\<0.0001.](elife-42149-fig6){#fig6}

*nprl3* mutant follicle cells are sensitive to genotoxic stress {#s2-5}
---------------------------------------------------------------

In humans, mutations in components of TSC sensitize cells to multiple forms of genotoxic stress ([@bib83]; [@bib16]; [@bib56]; [@bib80]). Thus, we predicted that the GATOR1 mutants, which have a two to three-fold increase in TORC1 activity, might have a globally diminished ability to respond to DNA damage. To test this model, we treated *nprl3* mutant larvae with the mutagen Methyl Methane Sulfonate (MMS) and compared the percentage of mutant animals that survived to adulthood relative to sibling heterozygous controls. MMS generates an array of DNA lesions including DSBs ([@bib67]). Notably, we found that *nprl3* mutant larvae were sensitive to DNA damage, with *nprl3/Df* transheterozygotes exhibiting a greater than 10-fold decrease in survival rates when exposed to 0.08% MMS ([Table 1](#table1){ref-type="table"}). These data support the idea that the GATOR1 complex plays a critical role in the response to genotoxic stress in both germline and somatic tissues.

10.7554/eLife.42149.014

###### *nprl2* and *nprl3* larvae are sensitive to the mutagen Methyl Methane Sulfonate.

                        MMS (0%)          MMS (0.04%)             MMS (0.08%)                                           
  --------------------- ----------------- ----------------------- --------------- --------------------- --------------- ---------------------
  *nprl2^1^/nprl2^1^*   27.6 (172/624)    **55.2%** (27.6/50)     17.6 (99/561)   **35.2%** (17.6/50)   13.7 (42/307)   **27.4%** (13.7/50)
  *nprl3^1^/Df*         27.1 (822/3038)   **81.4%** (27.1/33.3)   8 (198/2472)    **24%** (8.0/33.3)    2.4 (46/1925)   **7.2%** (2.4/33.3)

Eclosion after exposure to the mutagen Methyl Methane Sulfonate. Third instar larvae derived from heterozygous parents were treated with the indicated concentration of MMS and the surviving adult progeny were scored. % Obs represents the total percentage of adults of the indicated mutant genotype divided by the total number of adults scored. % of expected progeny represents the percentage of mutant adults observed (% Obs) divided by the expected percentage of mutant adults based on the parental cross. For *nprl2*, which is on the X chromosome, the expected percentage of mutant progeny was 50%. For *nprl3*, which is on the 3^rd^ chromosome, the expected percentage of mutant progeny was 33.3%. The observation that *nprl2* and *nprl3* have a lower percent survival than would be predicted at 0% MMS reflects the fact that these mutants are partially lethal in the absence of mutagen.

Obs.=Observed, \# of Obs = Number of mutant adults scored, \# of Total = Total number of adults scored.

Next, we wanted to determine if, as we observed in the female germline, mutations in GATOR1 components result in a delay in the repair of DSBs in somatic tissues. We exposed *Drosophila* females to 10 Gray (Gy) of γ-rays and then followed the dynamics of γ-H2Av staining in the somatically derived mitotically dividing follicle cells of the ovary. During *Drosophila* oogenesis, the somatic follicle cells divide mitotically until stage 6 of oogenesis at which point, they enter the endocycle. Prior to stage 6 of oogenesis wild-type and *nprl3/Df* follicle cells have very low levels of γ-H2Av staining ([Figure 7A,B](#fig7){ref-type="fig"}) ([@bib34]). One hour after exposure to 10Gy of γ-H2Av both wild-type and *nprl3/Df* mutants have a dramatic increase in follicle cells with γ-H2Av foci ([Figure 7A',B'](#fig7){ref-type="fig"}). However, 6 hr after irradiation while wild-type somatic cells have decreased numbers of γ-H2Av positive follicle cells due to rapid DNA repair, *nprl3/Df* females retain elevated numbers of follicle cells with γ-H2Av foci. ([Figure 7A--C](#fig7){ref-type="fig"}). Thus, as is observed in the female germline, in *nprl3* mutants the somatic cells of the ovary exhibit a delay in the repair of DSBs.

![Nprl3 promotes DNA repair in somatically derived follicle cells.\
Egg chambers from fed (**A**) WT and (**B**) *nprl3^1^/Df* females exposed to 10 Gy γ-irradiation. Ovaries were dissected at 0 hr (no irradiation) (**A, B**), 1 hr (**A', B'**) and 6 hr post-irradiation (**A'', B''**) and stained with antibodies against γ-H2Av (dsDNA breaks, Red), C(3)G (cyan) and the DNA dye DAPI (blue). (**C**) Quantification of γ-H2Av positive follicle cells from the indicated time points and genotypes. Note that an increased percentage of *nprl3/Df* follicle cells contain γ-H2Av foci 6 hr post irradiation relative to controls. Scale bar: 7 μm. Arrows denote γ-H2Av positive follicle cells.](elife-42149-fig7){#fig7}

GATOR1 inhibits retrotransposon expression in *Drosophila* {#s2-6}
----------------------------------------------------------

Genotoxic stress, resulting from DNA damage, has been implicated in transposon activation in multiple organisms ([@bib7]; [@bib97]; [@bib28]; [@bib4]). These results are consistent with the model that genotoxic stress promotes TE activation ([@bib71]; [@bib30]; [@bib103]). Therefore, we wanted to determine if retrotransposons expression is derepressed in the ovaries of GATOR1 mutants which exhibit several phenotypes consistent with increased genotoxic stress. Towards this end, we used qRT-PCR to compare expression levels for multiple retrotransposons in wild type versus *nprl2* and *nprl3* mutant ovaries. We found that *nprl2* and *nprl3* mutant ovaries have increased expression of multiple retrotransposons including TAHRE, Het-A, Indefix and Gypsy ([Figure 8A](#fig8){ref-type="fig"}). In contrast to *nprl2* and *nprl3* mutants, *Tsc1^RNAi^* germline resulted in little or no increase in retrotransposon expression ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). From these results, we conclude that the GATOR1 components *nprl2* and *nprl3* oppose retrotransposon expression in the female germline of *Drosophila*.

![GATOR1 opposes retrotransposon expression in parallel to p53.\
(**A**) Quantitative RT-PCR analysis of expression levels for retrotransposons in wild type, *nprl2^1^*, *nprl3^1^/Df*, *nanos-GAL4; UAS-Nprl3; nprl3^1^/Df*, *spnA^1^/spnA^093^* and *spnA^1^/spnA^1^* ovaries. (**B**) Quantitative RT-PCR analysis of expression levels for transposons in wild type, *nprl3^1^* and *mei-P22^P22^, nprl3^1^* ovaries. (**C**) Quantitative RT-PCR analysis of expression levels for the transposons in wild type, *p53^5A-1-4^, nprl3^1^/Df* and *nprl3^1^/Df, p53^5A-1-4^* ovaries. Rp49 is used for normalization. Fold expression levels are relative to wild type. Error bars represent SD of three independent experiments.](elife-42149-fig8){#fig8}

An additional possible connection between retrotransposon expression and the delayed repair of meiotic DSBs is suggested by our analysis of the DNA repair protein *spnA/Rad51*. As discussed above*, spnA* is a homolog of the DNA repair protein Rad51 which is conserved from yeast to humans ([@bib89]). Rad51 catalyzes strand exchange between homologous DNA molecules and thus facilitates homologous recombination. In *Drosophila, spnA/Rad51* mutant females fail to repair meiotic DSBs ([@bib89]). Intriguingly, we found that *spnA/Rad51* mutant ovaries had increased levels of retrotransposon expression ([Figure 8A](#fig8){ref-type="fig"}). Recently it has been reported that depletions of Rad51 result in the activation of Long interspersed repeat element 1 (LINE1) retrotransposons in HeLa cells ([@bib60]). Thus, our data are consistent with the model that the increased levels of retrotransposon expression observed in GATOR1 mutant ovaries may be due, at least in part, to the delay in the repair of meiotic DSBs.

In *nprl3* mutant ovaries, the activation of p53 and the increase in γ-H2Av foci is dependent on the production of meiotic DSBs ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). To determine if the expression of retrotransposons in *nprl3* mutant ovaries also requires the meiotic DSB machinery, we examined *nprl3, mei-P22* double mutants. Using qRT-PCR we observed that retrotransposon expression was largely, but not completely, suppressed in *nprl3, mei-P22* double-mutant ovaries. Thus, meiotic DSBs trigger the expression of retrotransposons during *Drosophila* oogenesis in the *nprl3* mutant background ([Figure 8B](#fig8){ref-type="fig"}). However, it is important to note that these data suggest that the GATOR1 complex may also impact retrotransposon expression independent of meiotic DSBs as indicated by the relatively modest rescue of TAHRE over-expression observed in *nprl3, mei-P22* double mutants ([Figure 8B](#fig8){ref-type="fig"}).

Finally, we wanted to determine if the GATOR1 complex inhibits the activation of retrotransposons through the p53 pathway. To answer this question, we performed epistasis analysis by generating double mutants that were homozygous for null alleles of both *p53* and *nprl3*. Strikingly, the *p53, nprl3* double mutant ovaries showed a dramatic increase in retrotransposon expression relative to either single mutant ([Figure 8C](#fig8){ref-type="fig"}). Thus, the *p53* and *nprl3* phenotypes are additive with respect to the inhibition of retrotransposon expression. These data strongly suggest that GATOR1 and p53 act through independent pathways to inhibit retrotransposon activation in the female germline during meiosis ([Figure 8C](#fig8){ref-type="fig"}).

Discussion {#s3}
==========

Recent evidence implicates metabolic pathways as important regulators of meiotic progression and gametogenesis ([@bib51]; [@bib21]; [@bib11]; [@bib87]; [@bib27]). Here we define a role for the GATOR complex, a conserved regulator of TORC1 activity, in the regulation of two events that impact germline genome stability: the response to meiotic DSBs and the inhibition of retrotransposon expression.

The GATOR complex and the response to meiotic DSBs {#s3-1}
--------------------------------------------------

We have previously shown that in *Drosophila,* mutations in the GATOR2 component *mio*, result in the constitutive activation of the GATOR1 pathway in the female germline but not in somatic tissues ([@bib37]; [@bib98]). Here we demonstrate that the tissue specific requirement for *mio* during oogenesis is due, at least in part, to the generation of meiotic DBSs during oogenesis. In *Drosophila*, only the female germline undergoes meiotic recombination and thus experiences the genotoxic stress associated with developmentally programmed DSBs ([@bib35]). We show that in *mio* mutants, blocking the formation of meiotic DSBs prevents the constitutive downregulation of TORC1 activity thus allowing for the growth and development of the oocyte. These data are consistent with the model that meiotic DSBs trigger the activation of a TORC1 inhibitory pathway that must be opposed and/or attenuated by the GATOR2 component Mio ([Figure 9](#fig9){ref-type="fig"}).

![A working model for the role of the GATOR complex in the response to meiotic DSBs.\
(**A**) After ovarian cysts enter meiosis, meiotic DSBs function to activate and/or maintain a GATOR1/TSC dependent pathway to ensure low TORC1 activity in early prophase of meiosis I. Low TORC1 activity promotes the timely repair of meiotic DSBs. Currently, whether meiotic DSBs directly activate the GATOR1/TSC pathway or an alternative pathway that works in concert with, or in parallel to, GATOR1/TSC is not known. (**B**) Subsequently, the GATOR2 component Mio is required to attenuate the activity of the GATOR1/TSC pathway, thus allowing for increased TORC1 activity and the growth and development of the oocyte in later stages of oogenesis.](elife-42149-fig9){#fig9}

While there are several possible models that might explain our data, we believe the most parsimonious explanation for our results is that the TORC1 inhibitory pathway activated by meiotic DSBs, involves both GATOR1 and TSC ([Figure 9](#fig9){ref-type="fig"}). This model is consistent with the ability of both GATOR1 and TSC depletions to rescue the *mio* mutant phenotype ([@bib98]). Additionally, recent reports indicate that GATOR1 and TSC act in a common pathway to downregulate TORC1 activity in response to multiple upstream inhibitory inputs ([@bib14]; [@bib75]; [@bib15]). Previously, we determined that in *Drosophila*, amino acid starvation induces a dramatic GATOR1/TSC dependent decrease in TORC1 activity in somatic tissues, that far exceeds any reduction in TORC1 activity observed in *GATOR2* null mutants ([@bib98]; [@bib8]). This observation strongly suggests that, in addition to the removal of the GATOR2 inhibition of GATOR1, there is an activation step that is required to fully potentiate the GATOR1/TSC pathway.

Thus, based on our data we propose the following model ([Figure 9](#fig9){ref-type="fig"}). Meiotic DSBs activate, or are required to maintain, a GATOR1/TSC dependent pathway that downregulates TORC1 activity in the female germline ([Figure 9A](#fig9){ref-type="fig"}). The GATOR2 component Mio is required to oppose or turnoff this pathway to prevent the constitutive downregulation of TORC1 activity in later stages of oogenesis. While we believe our data support the role of the GATOR1/TSC pathway, we concede that an alternative regulator of TORC1 activity may also be critical to the downregulation of TORC1 activity in response to meiotic DSBs.

GATOR1 and TSC promote the repair of meiotic DSBs {#s3-2}
-------------------------------------------------

Hyperactivation of TORC1 has been linked to defects in the DNA damage response in single celled and multicellular organisms ([@bib5]; [@bib20]; [@bib48]; [@bib80]; [@bib65]; [@bib104]). The observation that meiotic DSBs likely promote the GATOR1 dependent downregulation of TORC1 activity during *Drosophila* oogenesis, suggested that limiting TORC1 activity may be important to the regulation of meiotic DSB repair. In our previous work, we found that GATOR1 mutant ovaries had TORC1 activity levels approximately three times higher than those observed in wild-type ovaries ([@bib98]; [@bib8]). Here we demonstrate that GATOR1 mutant ovaries exhibit multiple phenotypes consistent with the misregulation of meiotic DSB repair including, an increase in the steady state number of Mei-W68/Spo-11 induced DSBs, the retention of meiotic DSBs into later stages of oogenesis and the hyperactivation of p53. ([@bib8]; [@bib99]). Importantly, RNAi depletions of *Tsc1* partially phenocopied the GATOR1 ovarian defects. Thus, the misregulation of meiotic DSBs observed in GATOR1 mutant oocytes are due to high TORC1 activity and not to a TORC1 independent function of the GATOR1 complex.

Epistasis analysis between the GATOR1 component *nprl3* and the Rad51 homolog *spnA*, strongly suggest that GATOR1 impacts the repair, rather than the generation, of meiotic DSBs. We determined that double mutants of *nprl2* and the Rad51 homolog *spnA*, which is required for the repair of meiotic DSBs, have approximately the same number of DSBs as *spnA* single mutants. These data are consistent with GATOR1 and *spnA* influencing the common process of DNA repair and are inconsistent with GATOR1 mutants producing supernumerary breaks.

Our observations on the role of the GATOR1 complex during *Drosophila* oogenesis are particularly intriguing in light of similar meiotic defects observed in a *npr3* mutants in *Saccharomyces cerevisiae* ([@bib42]). In the sporulation proficient strain SK1, *npr3* mutant cells enter meiosis and express the transcription factor and master regulator of gametogenesis IME1 with wild-type kinetics ([@bib42]). Subsequently, *npr3* mutants exhibit a mild delay in the generation of meiotic DNA breaks, but a substantial delay in the repair of meiotic DSBs ([@bib42]). Thus, yeast and *Drosophila* SEACIT/GATOR1 mutants share a common meiotic phenotype, the delayed repair of meiotic DSBs. These results raise the intriguing possibility that low TORC1 activity may be a common feature of the early meiotic cycle in many organisms.

Notably, our data indicate that the delay in the repair of meiotic DSBs in GATOR1 mutants is due to the hyperactivation of the TORC1 downstream target S6K. S6K is a critical downstream effector of TORC1 that impacts multiple essential cellular processes including, but not limited to cell growth, energy balance and aging ([@bib68]). Intriguingly, in mammals, S6K has been implicated in the regulation of the DNA damage response with hyperactivation of the TORC1-S6K pathway resulting in the accumulation of unrepaired DSBs and genome instability ([@bib52]; [@bib104]). Thus, similar to what is reported in mammals, our data are consistent with the model that the hyperactivity of the TORC1/S6K axis delays the repair of DSBs in *Drosophila*.

Finally, we determined that GATOR1 mutants have a diminished response to DSBs outside the female germline in somatic tissues of *Drosophila*. Similar to what is observed in TSC mutant cells in humans that have increased levels of TORC1 activity, we find that GATOR1 mutant embryos have a reduced ability to survive low levels of γ-irradiation ([@bib83]; [@bib16]; [@bib56]; [@bib80]). Moreover, in the somatic follicle cells of the ovary we observed a delay in the repair of DSBs after adult females are exposed to low levels of γ-irradiation. Thus, in *Drosophila* inappropriately high TORC1 activity delays the repair of DSBs in both the germline and somatic tissues.

GATOR1 opposes retrotransposon expression {#s3-3}
-----------------------------------------

The initiation of homologous recombination through the programmed generation of DNA double-stranded breaks (DSBs) is a universal feature of meiosis ([@bib73]; [@bib26]). DSBs represent a dangerous form of DNA damage that can result in dramatic and permanent changes to the germline genome ([@bib2]). To minimize this destructive potential, the generation and repair of meiotic DSBs is tightly controlled in space and time ([@bib62]). The activation of transposable elements represents an additional threat to genome integrity in germ line cells ([@bib12]; [@bib93]). Genotoxic stress, resulting from DNA damage, has been implicated in the deregulation of transposons in multiple organisms ([@bib7]; [@bib97]; [@bib28]; [@bib4]). Thus, germ line cells may be at an increased risk for transposon derepression due to the genotoxic stress associated with meiotic recombination. Consistent with this hypothesis, germ line cells have evolved extensive surveillance systems to detect and silence transposons beyond the pathways present in most somatic tissues ([@bib45]; [@bib50]; [@bib93]).

Previous studies have shown that DNA damage promotes the deregulation of retrotransposon in multiple organisms, including *Drosophila* ([@bib71]; [@bib7]; [@bib97]; [@bib28]; [@bib4]; [@bib76]; [@bib103]). In line with these studies, we find that in GATOR1 mutants, the DSBs that initiate meiotic recombination trigger the deregulation of retrotransposon expression. Similarly, *p53* mutant females derepress retrotransposon expression during oogenesis, but as observed in GATOR1 mutants, primarily in the presence of meiotic DSBs ([@bib103]). Double mutants of *nprl3, p53* exhibit a dramatic increase in retrotransposon expression relative to either *p53* or *nprl3* single mutants, implying that *p53* and GATOR1 act through independent pathways to repress retrotransposon expression in the female germline. One possibility is that both GATOR1 and p53 independently impact genome stability. Thus, disabling both pathways may have an additive effect on both genome stability and retrotransposon expression. Consistent with the hypothesis that genome instability drives retrotransposon expression, we find that mutants in *spnA/Rad51*, which fail to repair meiotic DSBs, also exhibit increased transcription of multiple retrotransposons. Intriguingly, the SpnA homolog Rad51, as well as other genes required for DNA repair, was recently identified in a high throughput screen for genes that suppress (Long Interspersed Element-1) LINE1 expression in mammalian tissue culture cells ([@bib60]).

However, our data also suggest that the GATOR1 complex may influence retrotransposon expression independent of the regulation of TORC1 activity. While both GATOR1 and TSC are required for the efficient repair of meiotic DSBs, in contrast to GATOR1 mutant ovaries, we observed little to no increase in retrotransposon expression in the *Tsc1* depleted ovaries. We believe reflects the incomplete depletion of Tsc1 by RNAi resulting in a reduced retention of meiotic DSBs relative to GATOR1 mutants ([Figure 6](#fig6){ref-type="fig"}). However, a second possibility is that the GATOR1 complex inhibits retrotransposon expression independent of TORC1 inhibition. As is observed with *spnA* the depletion of GATOR1 components, but not TSC components result in the activation of LINE1 expression in HeLa cells ([@bib60]). Taken together, these data hint that the GATOR1 complex may impact retrotransposon expression in the germline via two independent pathways: First by promoting the repair of meiotic DSBs through the downregulation of TORC1 activity and second via a pathway that functions independent of TORC1 inhibition.

Genes encoding components of the GATOR1 complex are often deleted in cancers ([@bib57]; [@bib41]; [@bib94]; [@bib3]). As is observed in GATOR1 mutants, cancer cells frequently have increased TORC1 activity, increased genomic instability and increased retrotransposon expression. Thus, in the future it will be important to identify the molecular mechanism by which the GATOR1 complex influences both the response to genotoxic stress and the expression of retrotransposons under both normal and pathological conditions.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type or\                              Designation                                                     Source or reference                                                       Identifiers                                                                 Additional\
  resource                                                                                                                                                                                                                                                            information
  --------------------------------------------- --------------------------------------------------------------- ------------------------------------------------------------------------- --------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  Gene (*Drosophila melanogaster*)              Atg1                                                            FlyBase                                                                   FBgn0260945                                                                 

  Gene (*Drosophila melanogaster*)              Iml1                                                            FlyBase                                                                   FBgn0035227                                                                 

  Gene (*Drosophila melanogaster*)              Loki                                                            FlyBase                                                                   FBgn0019686                                                                 

  Gene (*Drosophila melanogaster*)              Mio                                                             FlyBase                                                                   FBgn0031399                                                                 

  Gene (*Drosophila melanogaster*)              Mei-W68                                                         FlyBase                                                                   FBgn0002716                                                                 

  Gene (*Drosophila melanogaster*)              Mei-P22                                                         FlyBase                                                                   FBgn0016036                                                                 

  Gene (*Drosophila melanogaster*)              Nprl2                                                           FlyBase                                                                   FBgn0030800                                                                 

  Gene (*Drosophila melanogaster*)              Nprl3                                                           FlyBase                                                                   FBgn0036397                                                                 

  Gene (*Drosophila melanogaster*)              p53                                                             FlyBase                                                                   FBgn0039044                                                                 

  Gene (*Drosophila melanogaster*)              Spn-A                                                           FlyBase                                                                   FBgn0003479                                                                 

  Gene (*Drosophila melanogaster*)              S6K                                                             FlyBase                                                                   FBgn0283472                                                                 

  Gene (*Drosophila melanogaster*)              Thor                                                            FlyBase                                                                   FBgn0261560                                                                 

  Gene (*Drosophila melanogaster*)              Tsc1                                                            FlyBase                                                                   FBgn0026317                                                                 

  Genetic reagent (*Drosophila melanogaster*)   Atg1^Δ3D^, FRT 2A/Tm3, sb1                                      FlyBase, PMID: [24098761](https://www.ncbi.nlm.nih.gov/pubmed/24098761)   FBal0176392                                                                 

  Genetic reagent (*Drosophila melanogaster*)   iml1^1^                                                         FlyBase, PMID: [27672113](https://www.ncbi.nlm.nih.gov/pubmed/27672113)   FBal0325028                                                                 FlyBase symbol: iml1^1^

  Genetic reagent (*Drosophila melanogaster*)   loki^P6^                                                        FlyBase, PMID: [14729967](https://www.ncbi.nlm.nih.gov/pubmed/14729967)   FBal0216721                                                                 FlyBase symbol: lok^p6^

  Genetic reagent (*Drosophila melanogaster*)   mio^2^                                                          FlyBase, PMID: [14973288](https://www.ncbi.nlm.nih.gov/pubmed/14973288)   FBal0158954                                                                 FlyBase symbol: mio^2^

  Genetic reagent (*Drosophila melanogaster*)   mei-P22^P22^                                                    Bloomington Drosophila Stock Center                                       BDSC:4931                                                                   Genotype: y^1^w^1^/Dp(1;Y)y^+^; mei-P22^P22^; sv^spa-pol^

  Genetic reagent (*Drosophila melanogaster*)   mei-W68^1^                                                      Bloomington Drosophila Stock Center                                       BDSC:4962                                                                   FlyBase symbol: mei-W86^1^

  Genetic reagent (*Drosophila melanogaster*)   nprl2^1^                                                        FlyBase, PMID: [27672113](https://www.ncbi.nlm.nih.gov/pubmed/27672113)   FBal0325026                                                                 FlyBase symbol: nprl2^1^

  Genetic reagent (*Drosophila melanogaster*)   nprl3^1^                                                        FlyBase, PMID: [27166823](https://www.ncbi.nlm.nih.gov/pubmed/27166823)   FBal0319815                                                                 FlyBase symbol: nprl3^1^

  Genetic reagent (*Drosophila melanogaster*)   p53^5A-1-4^                                                     Bloomington Drosophila Stock Center                                       BDSC:6815                                                                   Genotype: y^1^ w^1118^; p53^5A-1-4^

  Genetic reagent (*Drosophila melanogaster*)   S6K^I-1^                                                        Bloomington Drosophila Stock Center                                       BDSC:32552                                                                  Genotype: y\[1\] w\[\*\]; S6k\[l-1\]/TM6B, P{y\[+t7.7\] ry\[+t7.2\]=Car20y}TPN1, Tb\[1\]

  Genetic reagent (*Drosophila melanogaster*)   spnA^1^                                                         Bloomington Drosophila Stock Center                                       BDSC:3322                                                                   Genotype: Dp(1;Y)B^S^; ru^1^ st^1^ e^1^ spn-A^1^ ca^1^/TM3, Sb^1^

  Genetic reagent (*Drosophila melanogaster*)   spnA^093A^                                                      FlyBase, PMID: [14592983](https://www.ncbi.nlm.nih.gov/pubmed/14592983)   FBal0151428                                                                 FlyBase symbol: spn-A^093A^

  Genetic reagent (*Drosophila melanogaster*)   thor^2^                                                         Bloomington Drosophila Stock Center                                       BDSC:9559                                                                   Genotype: y\[1\] w\[\*\]; Thor\[2\]

  Genetic reagent (*Drosophila melanogaster*)   Df(3L)ED4238                                                    Bloomington Drosophila Stock Center                                       BDSC:8052                                                                   Genotype: w^1118^; Df(3L)ED4238, P{3\'.RS5+3.3\'}ED4238/TM6C, cu^1^ Sb^1^

  Genetic reagent (*Drosophila melanogaster*)   Df(3L)ED4515                                                    Bloomington Drosophila Stock Center                                       BDSC:9071                                                                   Genotype: w^1118^; Df(3L)ED4515, P{3\'.RS5+3.3\'}ED4515/TM6C, cu^1^ Sb^1^

  Genetic reagent (*Drosophila melanogaster*)   nanos-Gal4                                                      FlyBase, PMID: [9501989](https://www.ncbi.nlm.nih.gov/pubmed/9501989)     FBrf0100715                                                                 FlyBase symbol: GAL4^VP16.nos.UTR^

  Genetic reagent (*Drosophila melanogaster*)   p53R-GFP                                                        FlyBase, PMID: [20522776](https://www.ncbi.nlm.nih.gov/pubmed/20522776)   FBrf0210965                                                                 FlyBase symbol: GFP^rpr.p53R.Tag:NLS(Unk)^

  Genetic reagent (*Drosophila melanogaster*)   MTD-Gal4                                                        Bloomington Drosophila Stock Center                                       BDSC:31777                                                                  Genotype: P{otu-GAL4::VP16.R}1, w^\*^; P{GAL4-nos.NGT}40; P{GAL4::VP16-nos.UTR}CG6325^MVD1^

  Genetic reagent (*Drosophila melanogaster*)   Tsc1 RNAi                                                       Bloomington Drosophila Stock Center                                       BDSC:35144                                                                  Genotype: y^1^ sc^\*^ v^1^; P{TRiP.GL00012}attP2

  Genetic reagent (*Drosophila melanogaster*)   Iml1 RNAi                                                       Bloomington Drosophila Stock Center                                       BDSC:57492                                                                  Genotype: y\[1\] sc\[\*\] v\[1\] sev\[21\]; P{y\[+t7.7\] v\[+t1.8\]=TRiP.HMC04806}attP40

  Genetic reagent (*Drosophila melanogaster*)   mCherry RNAi                                                    Bloomington Drosophila Stock Center                                       BDSC:35787                                                                  Genotype: y\[1\] sc\[\*\] v\[1\] sev\[21\]; P{y\[+t7.7\] v\[+t1.8\]=UAS mCherry.VALIUM10}attP2

  Genetic reagent (*Drosophila melanogaster*)   UAS-Nprl3                                                       FlyBase, PMID: [27672113](https://www.ncbi.nlm.nih.gov/pubmed/27672113)   FBrf0234182                                                                 FlyBase symbol: Nprl3^UASp.Tag:FLAG,Tag:HA^

  Genetic reagent (*Drosophila melanogaster*)   FRT80B                                                          Bloomington Drosophila Stock Center                                       BDSC:1988                                                                   Genotype: w\[\*\]; P{ry\[+t7.2\]=neoFRT}80B ry\[506\]

  Genetic reagent (*Drosophila melanogaster*)   FRT2A                                                           Bloomington Drosophila Stock Center                                       BDSC:1997                                                                   Genotype: w\[\*\]; P{w\[+mW.hs\]=FRT(w\[hs\])}2A

  Genetic reagent (*Drosophila melanogaster*)   FRT2A, ubi-GFPnls                                               Bloomington Drosophila Stock Center                                       BDSC: 5825                                                                  Genotype: w\[1118\]; P{w\[+mC\]=Ubi GFP.nls}3L1 P{Ubi-GFP.nls}3L2 P{w\[+mW.hs\]=FRT(w\[hs\])}2A

  Genetic reagent (*Drosophila melanogaster*)   hsFLP; FRT80B，lacZ                                             Bloomington Drosophila Stock Center                                       BDSC:6341                                                                   Genotype: P{hsFLP}22, y^1^ w^\*^; P{arm-lacZ.V}70 C P{neoFRT}80B

  Genetic reagent (*Drosophila melanogaster*)   UAS-mCherry RNAi                                                Bloomington Drosophila Stock Center                                       BDSC:35785                                                                  Genotype: y^1^ sc^\*^ v^1^; P{VALIUM20-mCherry}attP2

  Genetic reagent (*Drosophila melanogaster*)   nos-Flp                                                         This paper.                                                                                                                                           Lilly Lab.

  Antibody                                      Goat anti-Rabbit, mouse Alexa 488--568- 594--647- secondaries   Thermo Fisher                                                                                                                                         Immunofluorescence (1:1000)

  Antibody                                      anti-dS6K (Guinea pig polyclonal)                               PMID: [20444422](https://www.ncbi.nlm.nih.gov/pubmed/20444422)                                                                                        Western Blot (1:5000)

  Antibody                                      anti-phospho-Thr398-S6K (Rabbit polyclonal)                     Cell Signaling Technologies                                               9209; RRID:[AB_2269804](https://scicrunch.org/resolver/AB_2269804)          Western Blot (1:1000)

  Antibody                                      anti-GFP (Rabbit polyclonal)                                    Invitrogen                                                                A11122; RRID:[AB_221569](https://scicrunch.org/resolver/AB_221569)          Immunofluorescence (1:1000)

  Antibody                                      anti-g-H2Av (Rabbit poly clonal)                                Active Motif                                                              39117; RRID:[AB_2793161](https://scicrunch.org/resolver/AB_2793161)         Immunofluorescence (1:1000)

  Antibody                                      anti-C(3)G (clone 1A8 and 1G2) (Mouse monoclonal)               PMID: [15767569](https://www.ncbi.nlm.nih.gov/pubmed/15767569)                                                                                        Immunofluorescence (1:200)

  Antibody                                      anti-C(3)G (Rabbit polyclonal)                                  PMID: [12588841](https://www.ncbi.nlm.nih.gov/pubmed/12588841)                                                                                        Immunofluorescence (1:3000)

  Antibody                                      anti-1B1 (Mouse monoclonal)                                     Developmental Studies Hybridoma Bank                                      1B1; RRID:[AB_528070](https://scicrunch.org/resolver/AB_528070)             Immunofluorescence (1:100)

  Antibody                                      anti-g-H2Av (Mouse monoclonal)                                  Developmental Studies Hybridoma Bank                                      UNC93-5.2.1; RRID:[AB_2618077](https://scicrunch.org/resolver/AB_2618077)   Immunofluorescence (1:5000)

  Antibody                                      anti-Phospho-4E-BP1 (Thr37/46) (236B4) (Rabbit monoclonal)      Cell Signaling Technologies                                               2855;RRID:[AB_560835](https://scicrunch.org/resolver/AB_560835)             Immunofluorescence (1:200)

  Commercial assay or kit                       ECL                                                             PerkinElmer                                                               NEL105001EA                                                                 

  Chemical compound, drug                       methyl methanesulfonate (MMS)                                   Sigma                                                                     129925--5G                                                                  

  Commercial assay or kit                       RNAeasy Kit                                                     Qiagen                                                                    74104                                                                       

  Commercial assay or kit                       cDNA Reverse Transcription Kit                                  Thermo Fischer                                                            11752                                                                       

  Commercial assay or kit                       Power SYBR green mastermix                                      Thermo Fischer                                                            A25742                                                                      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly stocks {#s4-1}
----------

All fly stocks were maintained at 25°C on standard media. The *p53R-GFP* transgenic line was a gift from John M. Abrams ([@bib63]). The germline specific driver nanos-Gal4 was obtained from Ruth Lehmann ([@bib95]). The *spnA^093A^* stock was a gift from Ruth Lehmann ([@bib89]). The *nprl2^1^*, *nprl3^1^*, *iml1^1^*, and *UAS-Nprl3* were described previously ([@bib8]; [@bib99]). The stocks *w^1118^; Df(3L)ED4515, P{3\'.RS5+3.3\'}ED4515/TM6C, cu^1^ Sb^1^* (BDSC\#9071), *w^1118^; Df(3L)ED4238, P{3\'.RS5+3.3\'}ED4238/TM6C, cu^1^ Sb^1^* (BDSC\#8052), *w^1118^; P{neoFRT}82B P{Ubi-mRFP.nls}3R* (BDSC\#30555), *P{hsFLP}22, y^1^ w^\*^; P{arm-lacZ.V}70 C P{neoFRT}80B* (BDSC\#6341), *MTD-GAL4 (P{w\[+mC\]=otu-GAL4::VP16.R}1, w\[\*\] P{w\[+mC\]=GAL4 nos.NGT}40; P{w\[+mC\]=GAL4::VP16 nos.UTR}CG6325\[MVD1\],* BDSC\#31777), UAS-Tsc1 RNAi (y^1^ sc^\*^ v^1^; P{TRiP.GL00012}attP2, BDSC\#35144), UAS-mCherry RNAi (y^1^ sc^\*^ v^1^; P{VALIUM20-mCherry}attP2), *[y^1^](http://flybase.org/reports/FBal0018607)[w^1118^](http://flybase.org/reports/FBal0018186)*; *[p53^5A-1-4^](http://flybase.org/reports/FBal0138188)* (BDSC\#6815), *[y^1^](http://flybase.org/reports/FBal0018607)[w^1^](http://flybase.org/reports/FBal0018074)/[Dp(1;Y)y^+^](http://flybase.org/reports/FBab0010476)*; *[mei-P22^P22^](http://flybase.org/reports/FBal0088816)*; *[sv](http://flybase.org/reports/FBal0015991)[spa-pol](http://flybase.org/reports/FBal0015991)* (BDSC\#4931), *mei-W68^1^* (BDSC\#4932) and [*Dp(1;Y)B^S^*](http://flybase.org/reports/FBab0029200); [*ru^1^*](http://flybase.org/reports/FBal0014832) [*st^1^*](http://flybase.org/reports/FBal0016127) [*e^1^*](http://flybase.org/reports/FBal0003278) [*spn-A^1^*](http://flybase.org/reports/FBal0016029) [*ca^1^*](http://flybase.org/reports/FBal0001461)*/*[*TM3*](http://flybase.org/reports/FBba0000047), [*Sb^1^*](http://flybase.org/reports/FBal0015145) (BDSC\#3322) were obtained from Bloomington Stock Center.

Western blot analysis {#s4-2}
---------------------

The protocol was adapted from [@bib6]. Briefly 6 pairs of ovaries were freshly dissected in cell insect media and homogenized in 30 μl of 4x Laemmli loading sample buffer (Invitrogen, \#NP0008) containing 10x sample reducing agent (Invitrogen, \#NP009). Extracts were cleared by centrifugation and boiled for 10 min at 90°C. 10 μl of protein extract was loaded per lane on polyacrylamide gel (Invitrogen, \#NP0335). Proteins were separated and transferred to nitrocellulose membrane. Primary antibodies used were as follows: guinea pig anti-dS6K (gift of Aurelius Teleman,1:5,000,) ([@bib29]) and rabbit anti-phospho-Thr398-S6K (Cell Signaling Technologies \#9209, 1:1,000). HRP- conjugated secondary antibodies (Jackson Immunoresearch, AffiniPure anti-rabbit \#111-005-144 and anti-guinea pig \#106-005-003) were used. Blots were developed using the ECL detection system (PerkinElmer, \#NEL105001EA). Western blots were analyzed using ImageJ program (US National Institutes of Health).

Immunofluorescence and microscopy {#s4-3}
---------------------------------

Immunofluorescence was performed as previously described ([@bib33]; [@bib37]). Primary antibodies used were as follows: rabbit anti-GFP (Invitrogen, 1:1000); rabbit anti-γ−H2Av (Active Motif, 1:500); rabbit anti-C(3)G 1:3000 ([@bib33]); mouse anti-1B1 (Developmental Studies Hybridoma Bank, 1:100); mouse anti-γ-H2Av (Developmental Studies Hybridoma Bank, 1:5000); mouse anti-C(3)G (kindly provided by R. Scott Hawley, 1:200) ([@bib79]). Alexa-488 and Alex-594 (Invitrogen, 1:1000) secondary antibodies were used for fluorescence. After staining, ovaries were mounted in prolong gold antifade reagent with DAPI (Life Technology). Images were acquired on either a Leica SP5 confocal microscope or Zeiss LSM 880 with Airyscan confocal microscope.

γ-H2Av foci quantification {#s4-4}
--------------------------

To score the number of γ-H2Av foci per oocyte, ovaries were stained with antibodies against C(3)G and γ-H2Av as well as the DNA dye DAPI. Pro-oocytes and oocytes were identified by the pattern of anti-C(3)G staining ([@bib79]). Multiple Z-sections encompassing an entire region 2a pro-oocyte nucleus were acquired by Leica SP5 confocal microscope or Zeiss LSM 880 with Airyscan confocal microscopy. The obtained z-stacks of images were deconvolved to remove out-of-focus light and z-distortion with Huygens Professional software (Scientific Volume Imaging) and clearly defined γ-H2Av were counted manually in the ovarian cyst with the highest levels of γ-H2Av staining. Alternatively, 3D images were rendered by using Imaris software (Bitplane) and a graph workstation equipped with NVIDIA Quadro 3D vision system. Clearly defined γ-H2Av foci were visualized and counted by using Imaris spots module or ImageJ to define the total number of foci per nucleus.

MMS sensitivity assay {#s4-5}
---------------------

The assay was performed as described in [@bib23]. Briefly, 10 males and 10 virgin females were mated in vials for 2 days at 25°C. Parents were transferred into German food (Genesee Scientific, Cat\#66--115, Day 1) vials for 24 hr at 25°C and allowed to lay eggs. On Day two the parents were removed, and eggs were allowed to mature for 24 hr. Subsequently, the first and second instar larvae were treated with 250 μL of either 0.04% or 0.08% of the mutagen methyl methane sulfonate (MMS) (Sigma, Cat\#129925--5G). Control larvae were treated with 250 μL water. After eclosion, the number of heterozygous and homozygous mutant flies were determined, and the percentage of each genotype was calculated.

Gamma irradiation assay {#s4-6}
-----------------------

Wild type and mutant flies were fed wet yeast for two days and vials containing flies were exposed to 10Gy γ-IR in a Mark-1 γ-irradiator (JL Shepherd and Associates, San Fernando, CA). After irradiation, flies were incubated at 25°C and ovaries were collected for immunostaining assays at indicated time points.

Retrotransposon expression analysis {#s4-7}
-----------------------------------

Total RNA was isolated from dissected ovaries using the RNeasy Kit (Qiagen) and treated with DNase. cDNA was generated using High-capacity cDNA Reverse Transcription Kit (Thermo Fisher). Real-time PCR was performed with Power SYBR green Mastermix (Thermo Fisher) using the following primers:

1.  Rp49 Forward: CCGCTTCAAGGGACAGTATC;

2.  Rp49 Reverse: GACAATCTCCTTGCGCTTCT;

3.  TAHRE Forward: CTGTTGCACAAAGCCAAGAA;

4.  TAHRE Reverse: GTTGGTAATGTTCGCGTCCT;

5.  Het-A Forward: TCCAACTTTGTAACTCCCAGC;

6.  Het-A Reverse: TTCTGGCTTTGGATTCCTCG;

7.  Idefix Forward: TGAAGAAAAGAAGGGCGAGA;

8.  Idefix Reverse: TTCTGCTGTTGATGCTTTGG;

9.  Gypsy Forward: CCAGGTCGGGCTGTTATAGG;

10. Gypsy Reverse: GAACCGGTGTACTCAAGAGC.

The rp49 was used for normalization.
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Decision letter

Edgar

Bruce

Reviewing Editor

University of Utah

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The GATOR complex regulates an essential response to meiotic double-stranded breaks in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.

I have appended the reviews in their entirety below. As you can see, the reviews are reasonably well aligned, and the reviewers were favorable overall about your interesting study. However they have requested significant revisions that we hope can clarify some outstanding issues. These requests seem reasonable and I suggest you do your best to address those that are technically straightforward within a reasonable timeframe. While I agree with the reviewers that looking further into the GATOR dependency, determining whether DSBs in WT inhibit TOR, and how DSBs mechanistically affect TOR (is it via S6K?) are important directions, delineating a complete, precise mechanism is not necessarily essential for this paper to be published in *eLife*, so long as the conclusions are clear and warranted.

Reviewer \#1:

In this manuscript, Wei and colleagues delineate a pathway whereby double-stranded breaks (DSBs) inhibit mTORC1 activity via the GATOR1 complex, and this in turn allows repair of the double-stranded breaks. Overall, this is an interesting finding. A couple of the causality links of this story, however, need to be further tested to make the story solid:

1\) Figure 1C shows that inhibition of DSB formation leads to increased mTORC1 activity in a mutant condition where mTORC1 activity is aberrantly low due to loss-of-function of GATOR2 (*mio^2^* mutation). However, this does not show that in the wildtype condition DSBs affect mTOR activity. If the model is correct, the DSBs that occur normally in the ovary should be inhibiting mTORC1. Removing these DSBs should alleviate this suppression. So does the *mei-W68^1^* mutation increase S6K phosphorylation in the ovary compared to wildtype animals?

2\) The role of GATOR1 in mediating the effect of DSBs on mTORC1 needs to be tested more rigorously using loss-of-function epistasis. From the data in Figure 1C, the authors conclude DSBs affect mTORC1 via GATOR1. However, the data do not exclude the alternate possibility that DSBs and GATOR1 affect mTORC1 via parallel pathways. One way to test this is to assay S6K phosphorylation in ovaries of the following genotypes:

\- WT

\- *mei-W68^1^*

\- *iml1*- (GATOR1 loss-of-function)

\- *iml1-, mei-W69^1^* double mutants

In addition, this manuscript is lacking molecular mechanisms. How does mTORC1 activity affect DSB repair? Is it through delaying cell cycle progression? Is it through affecting transcription or translation of proteins required for repair? Alternatively, the upstream mechanism how DSBs affect GATOR1 activity is also missing. This may be a significant amount of work. Hence, it is an editorial decision how much molecular mechanism is wished in the present manuscript.

Reviewer \#2:

Wei and coworkers describe some interesting connections between TOR signaling, meiotic double strand breaks and genotoxic stress in the *Drosophila* ovary. This work builds on their previous characterization of the TORC1 regulators GATOR1 and GATOR2, the latter of which was shown to have germline-specific functions. Here they demonstrate that TORC1 activity is sensitive to DSB formation in the context of Mio/GATOR2 mutant ovaries, providing a possible explanation for these germline-specific effects. Under conditions of high TORC1 activity in GATOR1 mutants, resolution of meiotic DSBs is delayed, leading to increases in p53 activity, DNA damage sensitivity, and retrotransposon expression. Interestingly, some but not all of these effects are phenocopied by germline depletion of *Tsc1*, indicating some possible TORC1-independent functions of GATOR1.

This work is timely and well described, and adds to a growing literature examining the role of metabolism in gametogenesis. Overall the data are lovely and appear well controlled. Additional insight into the mechanisms behind these novel observations would strengthen the manuscript, and experiments that probe these issues in somatic cells would make it of more general interest to *eLife* readers.

1\) The authors demonstrate that in *mio* mutants, disruption of DSB formation leads to increased TORC1 activity, and they repeatedly describe this result as a GATOR-dependent response. However, the observation that TORC1 activity responds to the presence or absence of DSBs in ovaries lacking *mio* demonstrates that GATOR2 is not required for this response (in contrast to the model depicted in Figure 6), and would suggest that it is likely independent of GATOR1 as well. The role of GATOR1 is not directly tested here, and DSBs could in principle affect TORC1 activity through any one of multiple positive or negative TORC1 regulators/components. Without evidence that GATOR1 is specifically/selectively involved in this signal, I don\'t see the justification for calling this a GATOR1-dependent effect in the Title, Abstract, etc.

2\) The requirement for other well characterized TORC1 inputs (e.g., nutrient and insulin pathways) should be addressed. A more thorough probing of the mechanism by which DSBs affect TORC1 activity should be included here, and the effects of *mei-P22* mutation on TORC1 activity should be examined in otherwise wildtype animals and other mutations/conditions that lead to low TORC1 signaling.

3\) The proximal signals linking DSBs to TORC1 downregulation also should be addressed, by examining the genetic requirements for DSB checkpoint components in this response. Do exogenous, non-meiotic DSBs lead to similar effects, perhaps also in somatic cells, or does this require the context of a delayed synaptonemal complex?

4\) Similarly, the manuscript elegantly shows that increased TORC1 activity results in delayed or defective repair of meiotic DSBs, but is lacking in mechanistic detail. Here, examining the localization and activity of repair pathway components could prove insightful. Again, whether these observations reflect a general effect of high TORC1 activity on DSB repair or is limited to germline-specific lesions should be tested, as previous studies have described that low TORC1 activity can impair DSB repair/DNA damage response.

Reviewer \#3:

This paper analyzes the interesting intersection between the regulation of metabolism and meiotic progression. It is well known that entry of meiosis in budding yeast is regulated by nutrient availability. The PI has previously published that similar pathways, involving TORC1 and the GATOR1/2 complexes, regulate meiosis in *Drosophila*. This paper is interesting because it connects these regulators of metabolism to double strand break formation as well as p53 and stress responses. The data are convincing and support the conclusions. The most significant results are that DSBs trigger a stress response, which must be modulated by regulating the TORC1 pathway and preventing hyperactivation of p53. The data are interesting with significant impact in areas of regulating gametogenesis and meiotic recombination. There are several issues raised below that are mostly asking for more clarity in describing mutants and cytological results. A couple of experiments are suggested, which entail looking at a couple additional genotypes in the assays presented and thus should not be technically challenging unless there are viability issues. These are meant to generalize the results to the entire pathway presented in Figure 1 but are not essential for the main conclusions of the paper.

In several places are statements that TORC1 activity facilitates entry into meiosis (e.g. subsections "GATOR1 promotes the repair of meiotic DSB" and "GATOR2 opposes a GATOR1 dependent response to meiotic DSBs"). This seems to be mostly taken yeast results. In the absence of GATOR1 in flies, it might be predicted that oocytes either don\'t form oocytes or meiotic entry does not occur. In fact, Wei et al. reported a delay in meiotic entry in GATOR1 mutants. My question is whether the observed delay in meiotic entry may be more accurately described as a defect in progression. It is also critical to know if the mutants being analyzed in this paper are null alleles. Hypomorphs or RNAi could have leaky phenotypes when it comes to meiotic entry. In subsection "GATOR1 mutants hyperactivate p53 in response to meiotic DSBs", a *nprl3* is referred to as null, but this is in passing and this information should be much earlier. The authors should be careful to state whether the mutants are null and result in loss of GATOR1 or GATOR2 activity.

Paragraph three of subsection "GATOR1 promotes the repair of meiotic DSB": Is the persistence of DSBs in region 3 oocytes associated with dorsal-ventral polarity defects? This is observed in DSB repair mutants like *spnA*.

Subsection "GATOR1 mutants hyperactivate p53 in response to meiotic DSBs": The authors show that GATOR1 mutants hyperactivate p53. To show this is part of the TORC pathway, an experiment with p53 expression in a TORC mutant would be useful. Also, can the authors add p53 be in the model of Figure 6?

Subsection "GATOR1 inhibits retrotransposon expression in*Drosophila*": The most confusing results concern the relationship between the GATOR1, p53 and TEs. The effect of these mutants on TE expression is DSB dependent. However, while *nprl2/3* mutants have elevated TE expression, they also have elevated, rather than reduced, p53. One explanation is that the TORC pathway is downstream of p53. However, the phenotype of the p53 *nprl3* double is additive with respect to TE expression. As mentioned above, the correct interpretation of these experiments depends on both mutants being null alleles. It also suggests the elevated p53 levels in the *nprl* mutants is not the cause of the increased TE expression. More comment on these discrepancies would be appreciated. It would also be helpful to see a GATOR1-2 (*mio, nprl3*) double mutant, or a *mio* single, to determine if TE regulation is dependent on the pathway.

Subsection "GATOR2 opposes a GATOR1 dependent response to meiotic DSBs": this seems to be speculation (reasonable, but still a hypothesis) but stated more like fact -- that the function of Mio is required to regulate the response to meiotic DSBs. If this were true, the *mei-P22, mio* double would be as fertile as *mei-P22* single. Is that true? Can the authors comment on the small ovary phenotype? When does developmental arrest occur and is that related to some kind of checkpoint? Is it temporally separate from the induction and repair of DSBs?

Subsection "GATOR2 opposes a GATOR1 dependent response to meiotic DSBs": \"...regulation of meiotic DSB repair.\" and \"...meiotic repair of DSBs...\"

Subsection "GATOR1 opposes retrotransposon expression": the implication is that TE expression is upregulated by genotoxic stress, correct? Is that known or a correlation with DSB formation.

Figure 2G gives the impression that many of the mutants have more DSBs in region 2A than wildtype. This could be due to asynchrony and variation within the different pro-oocytes of region 2A. Thus, there should be *nprl* mutant pro-oocytes that have the same number of foci as wild-type, the difference being that as the oocytes progress, the number of foci increases because the DSBs are not repaired. The authors should correct his by showing oocytes of equivalent stage (difficult) or showing all pro-oocytes from one germarium to show how the progression of foci number changes with time.

Figure 2H: Add *spnA* to the graph. There appear to be two differences between the *spnA* and the GATOR phenotypes. First, the γ-H2Av foci persist in the nurse cells as well as the oocyte in *spnA* mutants. Second, 100% of *spnA* oocytes have region 3 foci.

Figure 6 and legend: The figure lacks a panel A. It might be better to put the germarium schematic at the top.

10.7554/eLife.42149.022

Author response

> Reviewer \#1:
>
> In this manuscript, Wei and colleagues delineate a pathway whereby double-stranded breaks (DSBs) inhibit mTORC1 activity via the GATOR1 complex, and this in turn allows repair of the double-stranded breaks. Overall, this is an interesting finding. A couple of the causality links of this story, however, need to be further tested to make the story solid:
>
> 1\) Figure 1C shows that inhibition of DSB formation leads to increased mTORC1 activity in a mutant condition where mTORC1 activity is aberrantly low due to loss-of-function of GATOR2 (mio^2^ mutation). However, this does not show that in the wildtype condition DSBs affect mTOR activity. If the model is correct, the DSBs that occur normally in the ovary should be inhibiting mTORC1. Removing these DSBs should alleviate this suppression. So does the mei-W68^1^ mutation increase S6K phosphorylation in the ovary compared to wildtype animals?

We performed two sets of experiments to address the reviewer's question. First, as suggested by reviewers \#1 and \#2, we examined TORC1 activity in *mei-w68^1^*single mutants by western blot and determined that *mei-w68^1^* mutant ovaries do not have increased TORC1 activity relative to wild-type ovaries (Figure 1). A similar result was observed in *mei-P22* mutants, which also fail to generate meiotic DSBs (Figure 1---figure supplement 3). We believe this observation is not surprising when one considers the anatomy of the *Drosophila* ovary. In wild-type ovaries, meiotic DSBs are present in only a small number of 16-cell cysts in the germarium and are repaired prior to the rapid growth of the egg chamber. Thus, ovarian cysts that contain meiotic DSBs represent an exceedingly small percentage of the tissue in the ovary. Thus, we reasoned it is unlikely that increasing TORC1 activity in only a small number of germarial ovarian cysts would result in an increase in TORC1 activity in the ovary that could be observed by western blot. However, please note that *spnA/Rad51* mutants, which retain meiotic DSBs throughout oogenesis, have reduced TORC1 activity relative to wild-type ovaries as measured by p-S6K levels assayed by western blot. These experiments are described in the second paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs", Figure 1 and Figure 1---figure supplement 2.

To obtain better resolution as to when and where meiotic DSBs impact TORC1 activity during oogenesis, we used an antibody against the phosphorylated form of the downstream TORC1 target 4E-BP. Briefly, we determined that "In contrast to what is observed in wild type, in *mio* mutant ovarian cysts, p4E-BP levels remain low in germline cells in region 2b and beyond (Figure 2C, arrow). Consistent with the western blot analysis, *mio, mei-w68* double mutant ovarian cysts have an approximately three-fold increase in p4E-BP staining in region 2b of the germarium relative to *mio* mutants (Figure 2C, E and H) Notably, the increase in TORC1 activity in the *mio, mei-w68* double mutants is restricted to the germline, consistent with blocking meiotic DSBs having cell autonomous effects on TORC1 activity in the germline. Additionally, consistent with our western blot analysis in Figure 1---figure supplement 2, ovarian cysts from *spnA/Rad51* mutants, which do not repair meiotic DSBs, have reduced levels of p4E-BP staining (Figure 2F). Taken together these data strongly suggest that *mio* is required to oppose/attenuate the downregulation of TORC1 activity triggered by the presence of meiotic DSBs." These new results are described in the third paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 2.

> 2\) The role of GATOR1 in mediating the effect of DSBs on mTORC1 needs to be tested more rigorously using loss-of-function epistasis. From the data in Figure 1C, the authors conclude DSBs affect mTORC1 via GATOR1. However, the data do not exclude the alternate possibility that DSBs and GATOR1 affect mTORC1 via parallel pathways. One way to test this is to assay S6K phosphorylation in ovaries of the following genotypes:
>
> \- WT
>
> \- mei-W68^1^
>
> \- iml1- (GATOR1 loss-of-function)
>
> \- iml1-, mei-W69^1^ double mutants

As suggested by the reviewer we performed epistasis analysis using the GATOR1 component *nprl3* and *mei-P22* a gene required for the generation of meiotic DSBs. We found that p-S6K levels were not significantly different in wild-type and *mei-p22* mutant ovaries. Moreover, *mei-p22, nprl3* double mutants had lower levels of p-S6K than *nprl3* single mutants. Thus, blocking the formation of meiotic DSBs does not in and of itself result in increased TORC1 activity. This experiment is described in the fourth paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and summarized in Figure 1---figure supplement 3.

> In addition, this manuscript is lacking molecular mechanisms. How does mTORC1 activity affect DSB repair? Is it through delaying cell cycle progression? Is it through affecting transcription or translation of proteins required for repair?

In order to examine why high TORC1 activity delays the repair of meiotic DSBs we examined three downstream targets of TORC1, *atg1*, 4E-BP/*thor* and S6K. Atg1 and 4E-BP are inhibited by TORC1 activity while S6K is activated by TORC1. Our results suggest that the delay in the repair of meiotic DSBs observed in GATOR1 mutants is due, at least in part, to the increased activity of S6K. Our negative results were also informative. We determined that null mutants of *atg1,* which isrequired for autophagy, as well as null mutants of the translational inhibitor 4E-BP/*thor,* do not alter the kinetics of meiotic DSB repair during oogenesis. Thus, we concluded it is highly unlikely that high TORC1 activity delays the repair of meiotic DSBs through the constitutive inhibition of autophagy or the inhibition of the translational inhibitor 4E-BP. These experiments are detailed in the first paragraph of the subsection "Co-depleting S6K rescues the increase in the steady state number of meiotic DSBs in *iml1* germline depletions" and Figure 4.

> Alternatively, the upstream mechanism how DSBs affect GATOR1 activity is also missing. This may be a significant amount of work. Hence, it is an editorial decision how much molecular mechanism is wished in the present manuscript.

Although we believe that defining the upstream pathway connecting meiotic DSBs to the TORC1 regulatory machinery is beyond the scope of this manuscript, we did explore the role of the ATM downstream target and checkpoint protein, Chk2. Chk2 is known as Loki in *Drosophila*. Specifically, we determined that removing Chk2/Loki activity partially rescues the *mio* mutant phenotype. From this result we conclude that Chk2/Loki is partially responsible for the downregulation of TORC1 activity observed in *mio* mutants. These results are presented in the last paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 1---figure supplement 4.

> Reviewer \#2:
>
> \[...\] This work is timely and well described, and adds to a growing literature examining the role of metabolism in gametogenesis. Overall the data are lovely and appear well controlled. Additional insight into the mechanisms behind these novel observations would strengthen the manuscript, and experiments that probe these issues in somatic cells would make it of more general interest to eLife readers.
>
> 1\) The authors demonstrate that in mio mutants, disruption of DSB formation leads to increased TORC1 activity, and they repeatedly describe this result as a GATOR-dependent response. However, the observation that TORC1 activity responds to the presence or absence of DSBs in ovaries lacking mio demonstrates that GATOR2 is not required for this response (in contrast to the model depicted in Figure 6), and would suggest that it is likely independent of GATOR1 as well. The role of GATOR1 is not directly tested here, and DSBs could in principle affect TORC1 activity through any one of multiple positive or negative TORC1 regulators/components. Without evidence that GATOR1 is specifically/selectively involved in this signal, I don\'t see the justification for calling this a GATOR1-dependent effect in the Title, Abstract, etc.

In trying to present all theoretical possible explanations for our data, we presented an overly complicated model that reflected possible roles for different GATOR2 components (such as *wdr24*) that were not examined in the current manuscript. This has now been corrected. The current model shows that Mio is not involved in regulating the initial downregulation of TORC1 activity in response to meiotic DSBs but is required to attenuate or turn off this response. This model is consistent with all of our data. The model is presented in Figure 9 and discussed in the Discussion subsection "The GATOR complex and the response to meiotic DSBs".

We agree with reviewer \#2 that we have not formally proven that the GATOR1/TSC pathway is activated by the presence of meiotic DSBs and have now adjusted the text accordingly. Importantly, we have altered the Abstract and have corrected our language throughout the manuscript to reflect the speculative nature of the connection between meiotic DSBs and the direct activation of a GATOR1/TSC dependent pathway. However, we strongly disagree that the most logical explanation for our results is that the response to meiotic DSBs activates a pathway that is completely independent of the GATOR/TSC pathway. We believe a much simpler explanation is that the regulation of TORC1 activity in the female germline requires two steps: (1) the activation of a GATOR1/TSC dependent pathway by meiotic DSBs and (2) the failure of Mio to attenuate or turnoff this activated pathway. This would be consistent with our published epistasis analysis which demonstrated that double mutants of *mio* and GATOR1 or TSC components rescue the *mio* mutant phenotypes (Wei et al., 2014). It would also be consistent with the observation that GATOR1 is the only identified downstream target of the GATOR2 complex. These ideas are now presented in the Discussion as a model.

> I don\'t see the justification for calling this a GATOR1-dependent effect in the Title.

Please note that we do not reference a GATOR1-dependent effect in the Title.

The title states:

"The GATOR complex regulates an essential response to meiotic double-stranded breaks in *Drosophila*"

We believe the title accurately reflects our data in that (1) the GATOR1 complex impacts the repair of meiotic DSBs and (2) the GATOR2 component Mio is required to attenuate a TORC1 inhibitory pathway that is activated by meiotic DSBs.

> 2\) The requirement for other well characterized TORC1 inputs (e.g., nutrient and insulin pathways) should be addressed.

Our apologies to the reviewer we are not sure what experiment is being suggested here. Please note that TSC, a well-known target of Akt1, is a component of the Insulin signaling pathway. However, we believe the examination of how meiotic DSBs impact insulin/Tor signaling beyond TSC and the GATOR complex are outside the scope of this manuscript.

> A more thorough probing of the mechanism by which DSBs affect TORC1 activity should be included here.

Although we believe that defining the upstream pathway connecting meiotic DSBs to the TORC1 regulatory machinery is beyond the scope of this manuscript, we did explore the role of the ATM downstream target and checkpoint protein, Chk2. Chk2 is known as Loki in *Drosophila*. Specifically, we determined that removing Chk2/Loki activity partially rescues the *mio* mutant phenotype. From this result we conclude that Chk2/Loki is partially responsible for the downregulation of TORC1 activity observed in *mio* mutants. These results are presented in the last paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 1---figure supplement 4.

> The effects of mei-P22 mutation on TORC1 activity should be examined in otherwise wildtype animals and other mutations/conditions that lead to low TORC1 signaling.

We performed two sets of experiments to address the reviewer's question. First, as suggested by reviewers \#1 and \#2, we examined TORC1 activity in *mei-w68^1^*single mutants by western blot and determined that, *mei-w68^1^* mutant ovaries do not have increased TORC1 activity relative to wild-type ovaries (Figure 1). A similar result was observed in *mei-P22* mutants, which also fail to generate meiotic DSBs (Figure 1---figure supplement 3). We believe this observation is not surprising when one considers the anatomy of the *Drosophila* ovary. In wild-type ovaries, meiotic DSBs are present in only a small number of 16-cell cysts in the germarium and are repaired prior to the rapid growth of the egg chamber. Thus, ovarian cysts that contain meiotic DSBs represent an exceedingly small percentage of the tissue in the ovary. Thus, we reasoned it is unlikely that increasing TORC1 activity in only a small number of germarial ovarian cysts would result in an increase in TORC1 activity in the ovary that could be observed by western blot. However, please note that *spnA/Rad51* mutants, which retain meiotic DSBs throughout oogenesis, have reduced TORC1 activity relative to wild-type ovaries as measured by p-S6K levels assayed by western blot. These experiments are described in the second paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 1 and Figure 1---figure supplement 2.

To obtain better resolution as to when and where meiotic DSBs impact TORC1 activity during oogenesis, we used an antibody against the phosphorylated form of the downstream TORC1 target 4E-BP. Briefly, we determined that "In contrast to what is observed in wild type, in *mio* mutant ovarian cysts, p4E-BP levels remain low in germline cells in region 2b and beyond (Figure 2C, arrow). Consistent with the western blot analysis, *mio, mei-w68* double mutant ovarian cysts have an approximately three-fold increase in p4E-BP staining in region 2b of the germarium relative to *mio* mutants (Figure 2C, E and H) Notably, the increase in TORC1 activity in the *mio, mei-w68* double mutants is restricted to the germline, consistent with blocking meiotic DSBs having cell autonomous effects on TORC1 activity in the germline. Additionally, consistent with our western blot analysis in Figure 1---figure supplement 2, ovarian cysts from *spnA/Rad51* mutants, which do not repair meiotic DSBs, have reduced levels of p4E-BP staining (Figure 2F). Taken together these data strongly suggest that *mio* is required to oppose/attenuate the downregulation of TORC1 activity triggered by the presence of meiotic DSBs." These new results are described in the third paragraph of the subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 2.

We believe that examining how mutations in additional components of the TORC1 machinery are impacted by blocking the formation of meiotic DSBs would be technically challenging, and beyond the scope of this manuscript.

> 3\) The proximal signals linking DSBs to TORC1 downregulation also should be addressed, by examining the genetic requirements for DSB checkpoint components in this response. Do exogenous, non-meiotic DSBs lead to similar effects, perhaps also in somatic cells, or does this require the context of a delayed synaptonemal complex?

Our examination of the role of Chk2 is described above. Additionally, we have previously published that ATR does not link DSBs to TORC1 downregulation in *mio* mutants (Iida and Lilly, 2004).

Whether DSBs in GATOR2 mutants trigger the constitutive downregulation of TORC1 activity in somatic cells will be an interesting area for future analysis.

> 4\) Similarly, the manuscript elegantly shows that increased TORC1 activity results in delayed or defective repair of meiotic DSBs, but is lacking in mechanistic detail.

In order to examine why high TORC1 activity delays the repair of meiotic DSBs we examined three downstream targets of TORC1, *atg1*, 4E-BP/*thor* and S6K. Atg1 and 4E-BP are inhibited by TORC1 activity while S6K is activated by TORC1. Our results suggest that the delay in the repair of meiotic DSBs observed in GATOR1 mutants is due, at least in part, to the increased activity of S6K. Our negative results were also informative. We determined that null mutants of *atg1,* which isrequired for autophagy, as well as null mutants of the translational inhibitor 4E-BP, do not alter the kinetics of meiotic DSB repair during oogenesis. Thus, we concluded it is highly unlikely that high TORC1 activity delays the repair of meiotic DSBs through the constitutive inhibition of autophagy or the inhibition of the translational inhibitor 4E-BP. These experiments are detailed in the first paragraph of the subsection "Co-depleting S6K rescues the increase in the steady state number of meiotic DSBs in *iml1* germline depletions" and Figure 4.

> Here, examining the localization and activity of repair pathway components could prove insightful.

We agree that the suggested experiments might provide important information for how TORC1 activity impacts DSB repair. However, because of the lack of available reagents these experiments would be extremely challenging and are beyond the scope of this manuscript.

> Again, whether these observations reflect a general effect of high TORC1 activity on DSB repair or is limited to germline-specific lesions should be tested, as previous studies have described that low TORC1 activity can impair DSB repair/DNA damage response.

To assess the general role of the GATOR1 complex in the regulation of DSB repair we examined the repair of γ-irradiation induced DSBs in the somatically derived follicle cells of the ovary by monitoring γ-H2Av staining. From this experiment we determined that high TORC1 activity can impact the repair of DSBs in somatic cell populations. Thus, both inappropriately low and high TORC1 activity can impair DSB repair. These experiments are detailed in the subsection "*nprl3* mutant follicle cells are sensitive to genotoxic stress" and Figure 7.

> Reviewer \#3:
>
> \[...\] There are several issues raised below that are mostly asking for more clarity in describing mutants and cytological results. A couple of experiments are suggested, which entail looking at a couple additional genotypes in the assays presented and thus should not be technically challenging unless there are viability issues. These are meant to generalize the results to the entire pathway presented in Figure 1 but are not essential for the main conclusions of the paper.
>
> In several places are statements that TORC1 activity facilitates entry into meiosis (e.g. subsections "GATOR1 promotes the repair of meiotic DSB" and "GATOR2 opposes a GATOR1 dependent response to meiotic DSBs"). This seems to be mostly taken yeast results. In the absence of GATOR1 in flies, it might be predicted that oocytes either don\'t form oocytes or meiotic entry does not occur. In fact, Wei et al. reported a delay in meiotic entry in GATOR1 mutants. My question is whether the observed delay in meiotic entry may be more accurately described as a defect in progression.

This is an excellent question. However, at this point in time we do not have the reagents to distinguish between a delay and a defect in progression. I am not certain what assay we could use to distinguish between these two possibilities. Because GATOR1 mutants frequently undergo an extra mitotic division, we hypothesized that GATOR1 mutants delay meiotic entry. Yet, we can't definitively rule out a defect in progression.

> It is also critical to know if the mutants being analyzed in this paper are null alleles. Hypomorphs or RNAi could have leaky phenotypes when it comes to meiotic entry. In subsection "GATOR1 mutants hyperactivate p53 in response to meiotic DSBs", a nprl3 is referred to as null, but this is in passing and this information should be much earlier. The authors should be careful to state whether the mutants are null and result in loss of GATOR1 or GATOR2 activity.

We thank the reviewer for pointing out this error. The GATOR1 (*nprl2, nprl3* and *iml1*) and *mio* alleles used in this study are all null alleles. We have now made this clear the first time the alleles are discussed.

> Paragraph three of subsection "GATOR1 promotes the repair of meiotic DSB": Is the persistence of DSBs in region 3 oocytes associated with dorsal-ventral polarity defects? This is observed in DSB repair mutants like spnA.

As suggested by the reviewer, we determined that eggs laid by *nprl3* null mutant females do not have DV patterning defects. This may reflect the fact that the repair of meiotic DSBs is delayed but not blocked in *nprl3* mutants. Alternatively, high TORC1 activity may override the translational repression of Gurken that drives the pattern defects observed in DNA repair mutants such as *spnA*. These results are presented in subsection "GATOR1 promotes the repair of meiotic DSB".

> Subsection "GATOR1 mutants hyperactivate p53 in response to meiotic DSBs": The authors show that GATOR1 mutants hyperactivate p53. To show this is part of the TORC pathway, an experiment with p53 expression in a TORC mutant would be useful.

As noted by reviewer \#2, previous work has established that some TORC1 activity is required for DSB repair (Ma et al., 2018). Thus, we would predict that TORC1 mutants would activate p53 in the female germline. Additionally, we have previously demonstrated that TORC1 null mutants result in a very early arrest of ovarian cyst development, often prior to the final mitotic cyst division (Wei et al., 2014). Moreover, we have observed that a small fraction of TORC1 mutants cysts undergo apoptosis. Finally, in unpublished data we see a slight activation of p53 in some GATOR2 mutants, including *mio,* which may be the result of low TORC1 activity. For all of these reasons, we believe the result from the suggested experiment would be difficult to interpret.

> Also, can the authors add p53 be in the model of Figure 6?

I think this would be difficult to do without causing confusion. We simplified our previous model at the request of the other reviewers. Currently, we believe that p53 is activated in GATOR1 mutants due to the delay in the repair of meiotic DSBs.

> Subsection "GATOR1 inhibits retrotransposon expression in *Drosophila*": The most confusing results concern the relationship between the GATOR1, p53 and TEs. The effect of these mutants on TE expression is DSB dependent. However, while nprl2/3 mutants have elevated TE expression, they also have elevated, rather than reduced, p53. One explanation is that the TORC pathway is downstream of p53. However, the phenotype of the p53 nprl3 double is additive with respect to TE expression. As mentioned above, the correct interpretation of these experiments depends on both mutants being null alleles. It also suggests the elevated p53 levels in the nprl mutants is not the cause of the increased TE expression. More comment on these discrepancies would be appreciated.

We appreciate the reviewer's comments and have now clearly stated that the epistasis analysis between *p53* and *nprl3* was performed with null alleles. We realized that the introduction to these experiments was extremely confusing. We have now reorganized as well as rewritten components of this section of the manuscript.

Our data indicate that p53 is necessary but not sufficient for repression of retrotransposon expression in the female germline. This result is consistent with our epistasis analysis, which demonstrated that GATOR1 and p53 function to suppress retrotransposon expression via independent pathways (Figure 8). Because they are functioning in independent pathways, increasing p53 activity would not be predicted to rescue the GATOR1 phenotypes.

As currently outlined in the discussion subsection "GATOR1 opposes retrotransposon expression", our data support the model that genotoxic stress, due to the delay in the repair of meiotic DSBs, is upstream of both increased p53 activity and derepressed retrotransposon expression.

> It would also be helpful to see a GATOR1-2 (mio nprl) double mutant, or a mio single, to determine if TE regulation is dependent on the pathway.

It is unclear what one might predict for a *mio* single mutant, decreased retrotransposon expression perhaps? Because we have not yet examined how *mio* and other GATOR2 components impact genome stability, we believe these experiments are beyond the scope of the manuscript. As noted above, low TORC1 activity, disrupts the response to DSBs in mammalian cells. Consistent with these reports, in unpublished data we see a slight activation of p53 in some GATOR2 mutants, including *mio*. Thus, we believe it would be difficult to interpret the results from these experiments.

> Subsection "GATOR2 opposes a GATOR1 dependent response to meiotic DSBs": this seems to be speculation (reasonable, but still a hypothesis) but stated more like fact -- that the function of Mio is required to regulate the response to meiotic DSBs. If this were true, the mei-P22 mio double would be as fertile as mei-P22 single. Is that true?

To address this question, we examined *mio, mei-w68* double mutants. We determined that blocking the formation of meiotic DSBs partially rescues the fertility deficit in *mio.* We propose the partial nature of the rescue may reflect the requirement for *mio* at multiple times during oogenesis as well as the decreased fertility associated with blocking the formation of meiotic DSBs. Notably, the GATOR2 complex has been reported to play a role in spindle assembly and thus may impact the construction of the efficiency of the meiotic divisions (Platani et al., 2015). Please note we tried to be conservative in the interpretation of this result stating: "*...*we demonstrate that the tissue specific requirement for Mio during oogenesis is due, at least in part, to the generation of meiotic DBSs during oogenesis." These results are presented in subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 1---figure supplement 1.

Please note, in *mio* mutantsDSBs trigger a small egg chamber phenotype. These data indicate that *mio* is required to regulate a physiological response to meiotic DSBs. We do not claim that *mio* directlyregulates the repair of meiotic DSBs.

> Can the authors comment on the small ovary phenotype. When does developmental arrest occur and is that related to some kind of checkpoint. Is it temporally separate from the induction and repair of DSBs.

We observe problems with oocyte specification in *mio* mutants beginning in late region 2a of the germarium (Iida and Lilly, 2004). However, while the oocyte fails to maintain the oocyte fate, other aspects of egg chamber development continue for some time including the endoreplication of nurse cell nuclei. Thus, it is difficult to establish exactly when *mio* egg chambers arrest their development. We have not been able to temporally separate the induction of meiotic DSBs and the failure to properly maintain oocyte fate in *mio* mutants. Both these events occur as early as region 2a.

We explored the role of the ATM downstream target and checkpoint protein, Chk2. Chk2 is known as Loki in *Drosophila*. Specifically, we determined that removing Chk2/Loki activity partially rescues the *mio* mutant phenotype. From this result we conclude that Chk2/Loki is partially responsible for the downregulation of TORC1 activity observed in *mio* mutants. These results are presented in subsection "Mio prevents the constitutive inhibition of TORC1 activity in response to meiotic DSBs" and Figure 1---figure supplement 4.

Additionally, we have previously published that ATR does not link DSBs to TORC1 downregulation in *mio* mutants (Iida and Lilly, 2004).

> Subsection "GATOR1 opposes retrotransposon expression": the implication is that TE expression is upregulated by genotoxic stress, correct? Is that known or a correlation with DSB formation.

It has been noted by Barbara McClintock and others, that genotoxic stress activates retrotransposons although the exact mechanism of activation remains elusive (Beauregard, Curcio, and Belfort, 2008; Bradshaw and McEntee, 1989; Hagan, Sheffield, and Rudin, 2003; Walbot, 1992). We proposed that "germ line cells may be at an increased risk for transposon derepression due to the genotoxic stress associated with meiotic recombination." To test the model that unrepaired meiotic DSBs trigger retrotransposon expression we examined retrotransposon transcript levels in *spnA/Rad51* mutant ovaries and determined that they were increased relative to wild type (Figure 8). These data are consistent with work from HeLa cells that LINE1 element activity is increased in Rad51 depleted cells (Liu et al., 2018). This work is presented in subsection "GATOR1 inhibits retrotransposon expression in *Drosophila*" and Figure 8.

> Figure 2G gives the impression that many of the mutants have more DSBs in region 2A than wildtype. This could be due to asynchrony and variation within the different pro-oocytes of region 2A. Thus, there should be nprl mutant pro-oocytes that have the same number of foci as wild-type, the difference being that as the oocytes progress, the number of foci increases because the DSBs are not repaired. The authors should correct his by showing oocytes of equivalent stage (difficult) or showing all pro-oocytes from one germarium to show how the progression of foci number changes with time.

We found that GATOR1 mutants had an increase in the number of γ-H2Av foci relative to wild type. This is not just an impression. We used a modified method of counting γ-H2Av foci that was originally presented in Mehrotra and McKim (Mehrotra and McKim, 2006). For both mutant and wild type germaria, we reported the number of foci in the ovarian cyst that had the highest levels of γ-H2Av staining in the oocyte in region 2A of the germarium. As can be seen in Figure 3, this number can be the same as is observed in wild type germaria. However, on average, the number of foci in the GATOR1 mutants is higher. GATOR1 mutant germarium are somewhat misshapen, at least in part, because of the large number of 32 cell cysts. Thus, it would be difficult to establish equivalent stages in the germarium in mutant and wild type. Additionally, it is not clear how scoring all of the oocytes within a cyst, which would be a large amount of work, might alter our interpretation of the role of GATOR1 in the response to meiotic DSBs.

*Figure 2H: Add spnA to the graph. There appear to be two differences between the spnA and the GATOR phenotypes. First, the* γ*-H2Av foci persist in the nurse cells as well as the oocyte in spnA mutants. Second, 100% of spnA oocytes have region 3 foci.*

We did not quantify the retention of γ-H2av foci phenotype, γ-H2av foci also persist in the nurse cells in GATOR1 mutants although this is to a lesser degree then observed in *spnA* mutants (Figure 3). As suggested by the reviewer we added *spnA* mutants to the graph in Figure 3I-K.

> Figure 6 and legend: The figure lacks a Panel A. It might be better to put the germarium schematic at the top.

We have altered and simplified the model as suggested by several reviewers (Figure 9).

[^1]: These authors contributed equally to this work.
